Advances in sheep analgesia by Bortolami, Elisa
    
  
      
 
 
 
UNIVERSITÀ DEGLI STUDI DI PADOVA 
 
Dipartimento di Medicina Animale, Produzioni e Salute 
 
DOTTORATO DI RICERCA IN : SCIENZE VETERINARIE 
CICLO XXVII 
 
 
 
 
 
Advances in sheep analgesia 
 
 
 
 
 
 
 
 
Coordinatore : Ch.mo Prof. Gianfranco Gabai 
Supervisore : Ch.ma Prof.ssa Giulia Maria De Benedictis 
 
    
Dottorando : Elisa Bortolami 
       
  
  
DEDICATION AND ACKNOWLEDGEMENTS 
 
I would like to thank my supervisor, Dr Giulia Maria De Benedictis, for the 
constant guidance and support she provided me over the last ten years. Thanks 
to her I started being interested in veterinary anaesthesia and analgesia and 
thanks to her I was introduced into the research world as a veterinary student. I 
could not have achieved any professional title without her support as a teacher, 
which expanded into a long lasting friendship. 
After flying out of the Padua nest, the experience at Bristol University 
consolidated my clinical and research skills; I had the great honour to meet and 
work with Dr Joanna Murrell, an outstanding researcher and clinician who has 
always and constantly been available to help and guide me. I am greatly indebted 
to her for advice, constructive comments and discussion during the preparation of 
the main study of the thesis and for proof reading assistance. Not only she 
massively helped with from the scientific point of view, but thanks to her 
encouragement and advice I could also overcome stressful times during the last 
few years and I could target important professional goals. Thanks to all the 
clinical and research anaesthesia team at Bristol University, and in particular to 
Mr James Hunt and Dr Nicola Grint for proof reading and support. 
Many thanks are due to Dr Barbara Contiero, from University of Padua, for 
providing advice on statistical analysis of data collected, Prof. Giorgia della 
Rocca and Dr Alessandra di Salvo, from University of Perugia, for taking part at 
the tramadol study and Dr Mario Giorgi, from Pisa University, for the 
pharmacokinetic analysis. I would also like to thank Alice Depase (DVM), Yochai 
Avital (DVM) and Roberta Fanecco (DVM) for technical support. Many thanks to 
Dr Polly Taylor and Michael Dixon for their useful and constructive advice on the 
use of the mechanical nociceptive threshold device. 
I gratefully acknowledge Prof. Bruno Cozzi, from Padua University, for his 
mentoring since I was a first year veterinary student, and Prof. Flaviana Gottardo, 
from University of Padua, for the exchange of ideas and help. A special thank to 
Prof. Gianfranco Gabai, from Padua University, for his support. 
Finally, a special thank to my husband and my family for enabling me to make 
the most of every opportunity available, and for all their encouragement and 
support. 
 
 
  
  
LIST OF PUBLICATIONS INCLUDED IN THIS THESIS 
 
E.Bortolami, G. della Rocca. A. Di Salvo, M. Giorgi, T.W. Kim, M. Isola, 
G.M. De Benedictis. Pharmacokinetics and antinociceptive effects of 
tramadol and its metabolite O-desmethyltramadol following intravenous 
administration in sheep. The Veterinary Journal (2015), 
http://dx.doi.org/doi:10.1016/j.tvjl.2015.04.011. 
 
E. Bortolami, G. della Rocca. A. Di Salvo, M. Giorgi, T.W. Kim, G.M. De 
Benedictis. Pharmacokinetics of tramadol and its metabolite M1 following 
intravenous administration in Sheep. Abstract presented at the Association 
of Veteriary Anaesthetists Spring meeting, 24th-25th April 2014, 
Nottingham Uk. Veterinary Anaesthesia and Analgesia (2014); 41(6): A61. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
TABLE OF CONTENTS 
 
RIASSUNTO                          1 
 
ABSTRACT                 3 
 
CHAPTER 1: Introduction              5 
1.1 Pain pathophysiology              5 
1.1.1 Definition of pain             5 
1.1.2 Classification of pain            6 
1.1.3 Sensory processing             6 
1.1.4 Pain modulation             8 
1.2 Sheep: experimental model and farm animal        11 
1.2.1 Sheep: experimental model         11 
1.2.2 Sheep: farm animal           13 
1.3 Pain recognition and assessment in sheep         14 
1.3.1 Pain recognition in animals         14 
1.3.2 Pain assessment in sheep          17 
1.4 Nociceptive threshold testing           26 
1.4.1 Quantification of pain: nociceptive threshold testing 26 
1.4.2 Classification of nociceptive stimulation        30 
1.4.3 Nociceptive threshold testing in sheep        35 
1.5 Pain treatment in sheep           40 
1.5.1 Opioids            40 
1.5.2 Tramadol            41 
1.5.3 Alpha2-adrenoceptor agonists         43 
1.5.4 Non-steroidal anti-inflammatory drugs        44 
1.5.5 Local anaesthetics           44 
1.5.6 Dissociative anaesthetics          45 
1.6  AIMS OF THE THESIS           46 
 
 
 
  
CHAPTER 2: Reported analgesic administration to sheep undergoing  
    experimental surgical procedures         47 
2.1  Introduction             47 
2.2  Materials and methods           48 
2.3  Results             50 
2.4  Discussion            60 
2.5  Conclusions            64 
 
CHAPTER 3: Attitudes of Italian veterinarians to pain and the use of  
 analgesics in sheep          67 
3.1 Introduction            67 
3.2  Materials and methods           68 
3.3  Results             70 
3.4  Discussion            83 
3.5  Conclusions            88 
 
CHAPTER 4: Pharmacokinetics and antinociceptive effects of  
   tramadol and its metabolite M1 following  
 intravenous administration in sheep        89 
4.1 Introduction            89 
4.2 Materials and methods           90 
4.3 Results             94 
4.4 Discussion          104 
4.5 Conclusions          108 
 
CHAPTER 5: General discussions        109 
 
REFERENCES           111 
 
ANNEX A            139 
 
 
 1 
 
RIASSUNTO 
 
La pecora domestica (Ovis aries) è una delle specie animali più 
comunemente allevate ed utilizzate nella ricerca biomedica; nonostante 
questo l’analgesia in questo animale è stata a lungo trascurata. 
I primi due studi presentati in questa tesi sono stati elaborati allo scopo di 
valutare la somministrazione di analgesici nell’ambito clinico e 
sperimentale. Il terzo studio valuta la farmacocinetica e gli effetti 
antinocicettivi del tramadolo e del suo metabolita O desmethyltramadol 
(M1). 
Il primo studio consiste in una meta-analisi sull’ uso di farmaci analgesici 
riportato nelle pecore utilizzate a fini sperimentali. Studi riguardanti 
procedure sperimentali in pecore effettuati in anni selezionati (2008-2011-
2014) sono stati identificati utilizzando un motore di ricerca. In totale, sono 
stati selezionati 75 articoli scientifici. Lo studio evidenzia mostra che la 
terapia antalgica spesso non viene accuratamente riportata. 
Il secondo studio consiste in un questionario on line redatto allo scopo di 
valutare l’attuale approccio dei veterinari italiani, che si occupano della 
specie ovina, alla valutazione ed al trattamento del dolore in questa 
specie. Il questionario era diviso in cinque sezioni riguardanti i dati 
demografici, l’uso di farmaci analgesici a tecniche utilizzate per apportare 
analgesia, e l’approccio utilizzato dai veterinari nella valutazione e 
trattamento del dolore nella specie ovina, ed, infine, la loro conoscenza 
riguardo tale argomento. Un numero limitato di veterinari ha completato il 
questionario. I farmaci più comunemente utilizzati dai veterinari che hanno 
risposto al questionario sono i farmaci antiinfiammatori non steroidei e gli 
anestetici locali. Secondo l’opinione dei veterinari, le ragioni principali per 
cui la terapia analgesica non viene effettuata nella specie ovina erano la 
mancanza di farmaci registrati, il loro costo, i tempi di sospensione e la 
regolamentazione riguardante il loro utilizzo. La maggior parte dei 
veterinari si dimostrava interessata a migliorare le proprie conoscenze 
riguardo l’analgesia nella specie ovina. 
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Il terzo studio investiga la farmacocinetica e gli effetti antinocicettivi del 
tramadolo ed M1 dopo somministrazione endovenosa nelle pecore. Due 
dosi di tramadolo, 4 mg/kg (T4) e 6 mg/kg (T6), e soluzione salina (SAL) 
sono state somministrate in due minuti a sei pecore adulte e sane in uno 
studio randomizzato “in cieco” con un periodo di sospensione di due 
settimane. A tempi predeterminati, sono stati effettuati i prelievi di sangue 
per l’analisi farmacocinetica, e sono stati registrati i parametri fisiologici e i 
valori dopo stimolazione nocicettiva meccanica (MNT). Tramadolo ed M1 
presentano rispettivamente una cinetica bi-compartimentale e non-
compartimentale. I parametri farmacocinetici sono simili per le due dosi T4 
e T6. Le concentrazioni plasmatiche di tramadolo ed M1 sono 
rapidamente diminuite. I parametri fisiologici non sono risultati 
statisticamente diversi tra i gruppi. Non sono stati evidenziati effetti 
antinociettivi del tramadolo; infatti i valori di MNT non sono risultati 
statisticamente diversi tra i gruppi. 
Concludendo, questi studi hanno dimostrato che ci sono ampi margini di 
miglioramento nella valutazione e trattamento del dolore nella specie 
ovina sia in ambito sperimentale sia clinico. Inoltre, sono necessari studi 
sperimentali e clinici riguardanti la farmacocinetica e farmacodinamica di 
farmaci analgesici nella specie ovina al fine di migliorarne il benessere. 
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ABSTRACT 
 
Sheep (Ovis aries) are widely used in experimental settings and breeding 
system, nevertheless pain treatment in this species seems to be 
overlooked. 
The first two studies described in this thesis were designed to evaluate 
administration of analgesics both in the experimental and clinical setting. 
The third study evaluated the pharmacokinetics and antinociceptive effects 
of tramadol and its metabolite O-desmethyltramadol (M1) in sheep in a 
preclinical model of pain. 
The first study consisted of a meta-analysis of the reported use of 
analgesics in sheep for experimental purposes. Studies involving 
experimental procedures in sheep carried out in selected years (2008-
2011-2014) were identified using a search engine. A total of 75 papers 
were selected. The study showed that analgesic treatment was often not 
accurately reported. 
The second study consisted of an on-line questionnaire evaluating the 
current attitudes of Italian practitioners to assessment and treatment of 
pain in sheep. The questionnaire consisted of five sections regarding the 
demographic data, analgesic drugs and techniques used to treat pain, 
attitudes to pain relief and assessment of pain and the knowledge on the 
topic of sheep analgesia. Only a modest number of questionnaires were 
returned. The most commonly used drugs by sheep practitioners who 
replied to the questionnaire were non steroidal anti-inflammatory drugs 
and local anaesthetics. In the practitioners’ opinion the main reasons for 
analgesic drugs not to be administered to sheep was the lack of licensed 
drugs followed by costs, withholding times and regulations. The vast 
majority of practitioners were interested in improving their knowlwdge on 
sheep analgesia. 
The third study investigated the pharmacokinetic profile and 
antinociceptive effect of tramadol and M1 following intravenous 
administration in sheep. Six healthy adult sheep were administered 4 (T4) 
and 6 (T6) mg/kg of tramadol (T) and saline (SAL) over 2 minutes in a 
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cross over design with a two weeks wash out period. At predetermined 
time points blood samples were collected, physiological parameters and 
mechanical nociceptive threshold (NMT) values were recorded. Tramadol 
and M1 fitted a two compartmental model and a non compartmental model 
respectively. Pharmacokinetic parameters were similar for T4 and T6. 
Tramadol and M1 plasma concentrations decreased rapidly. Physiological 
parameters were not statistically different between groups. No mechanical 
antinociceptive effects of tramadol were detected, as MNT values did not 
statistically differ between groups. 
In conclusion, these studies showed that there is great scope for 
improvement in pain assessment and treatment in sheep both in the 
research than clinical settings. Moreover more experimental and clinical 
studies regarding the pharmacokinetic and pharmacokinamic effects of 
analgesic drugs in sheep are advocated in order to improve their welfare. 
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Chapter 1 
 
INTRODUCTION 
_____________ 
 
 
1.1 Pain pathophysiology 
 
1.1.1 Definition of pain 
 
The International Association for the Study of Pain (IASP) define pain as a 
“sensory and emotional experience associated with real or potential 
injuries, or described in terms of such injuries” (Loeser & Treede 2008). 
This definition was then modified to include non-verbal humans who 
cannot self-report their feelings and the comment that “the inability to 
communicate verbally does not negate the possibility than an individual is 
experiencing pain and is in need of appropriate pain-relieving treatment”. It 
was also clarified that “pain is always subjective”. 
An exhaustive definition of animal pain was provided by Molony and Kent: 
animal pain was defined as “an aversive sensory and emotional 
experience representing an awareness by the animal of damage or threat 
to the integrity of its tissues; it changes the animal’s physiology and 
behaviour to reduce or avoid damage, to reduce the likelihood of 
recurrence and to promote recovery; unnecessary pain occurs when the 
intensity or duration of the experience is inappropriate for the damage 
sustained or when the physiological and behavioural responses to it are 
unsuccessful at alleviating it” (Molony & Kent 1997). 
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1.1.2 Classification of pain 
 
Pain can be classified according to different temporal phases. Acute pain 
occurs at the moment of the injury and can be followed by sub-acute pain. 
If pain is not properly treated or if the cause of pain is not eliminated 
chronic pain can arise (Millan 1999). 
Another way to classify pain is by the source within the body as visceral, 
somatic or neuropathic pain; these types of pain differ by 
neurophysiological characteristics (McMahon 1997). 
Pain can also be categorized as “adaptive” whose function is to protect the 
body from injury or injury progression or “maladaptive”, where pain itself is 
the disease (Woolf 2004). 
Adaptive pain includes nociceptive pain and inflammatory pain. 
The term nociception is used to define the processing of stimuli that 
damage (or may potentially damage) normal tissue into a conscious pain 
experience. Nociception is the physiological side of pain, without the 
aversive emotional component, as commented by Rutherford (Rutherford 
2002). 
 
1.1.3 Sensory processing 
 
Sensory processing consists of different steps: transduction, transmission, 
modulation, projection and perception (Shilo & Pascoe 2014). 
 
Transduction 
A noxious stimulus (mechanical, thermal or chemical) is converted into 
electrical activity by nociceptors, which constitute the free endings of 
afferent primary peripheral neurons. The cell bodies of these neurons are 
located in the dorsal root ganglia and the trigeminal ganglion and extend 
central axonal endings into the dorsal horn of spinal cord or in the 
trigeminal nucleus caudalis in the caudal, where they synapse with second 
order neurons. Inflammatory mediators, such as bradykinin, serotonin, 
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prostaglandins, cytokines, are released from damaged tissue and can 
stimulate nociceptors directly medulla (Dubin & Patapoutian 2010). 
 
Transmission 
The neural impulse is propagated from the site of transduction, skin or 
viscera, to the dorsal horn of the spinal cord. Different nerve fibres are 
involved in this phase. The speed of transmission depends on the 
diameter of axons of sensory neurons and whether or not they are 
myelinated (Dubin & Patapoutian 2010). Aδ small myelinated fibres 
account for the initial “stabbing” of well localised pain, and respond to 
mechanical and thermal stimuli; while small non myelinated C fibres 
account for the “burning” more diffuse pain (McMahon 1997). C fibres are 
polymodal and respond to chemical, mechanical and thermal stimuli. In 
addition to Aδ and C fibres, there are also Aβ fibres carrying non noxious 
stimuli, such as touch. Aβ fibres are of large diameter and highly 
myelinated and are characterised by rapid signal conduction (Almeida et al 
2004). 
 
Modulation 
Aδ and C fibres synapse with secondary afferent neurones in the dorsal 
horn of the spinal cord, where modulation takes place (Shilo & Pascoe 
2014). At this level, there are sensory nuclei that receive and process 
incoming somatosensory information and can augment, inhibit or modify 
this information. 
The dorsal horn is histologically organised into ten layers, called Rexed 
laminae. These second order neurons include projection cells, 
interneurons and propriospinal neurons. Propriospinal neurons belong to a 
polysynaptic pathway and control locomotion, reflex responses and 
transfer information to the brain. Interneurons can have either inhibitory or 
excitatory properties and release γ- aminobutyric acid (GABA) and/or 
glycine or glutamate and/or substance P respectively. Interneurons convey 
information from primary afferents to projection neurons. Projection 
neurons and interneurons responding to noxious stimuli only are located 
primarily in lamina I and lamina II, while the so called “wide dynamic range 
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neurons” WDR are located in lamina V and respond to both innocuous and 
noxious input (Basbaum & Jessell 2000). WDR neurons are involved in 
descending control and in induction of long term inflammatory or 
neuropathic pain states. 
 
Projection 
Nociceptive information are conveyed to the brain through the spinal cord, 
via two most important pathways: the spinothalamic tract and the 
spinoreticular tract (Shilo & Pascoe 2014). 
In the spinothalamic tract, secondary afferent neurones decussate and 
ascend in the contralateral spinothalamic tract to nuclei in the thalamus. 
Third order neurones then ascend from this area to the somatosensory 
cortex, the periaqueductal grey matter (PAG) and convey information 
regarding pain localization. 
In the spinoreticular tract fibres ascend the contralateral cord and reach 
the brainstem reticular formation; from here fibres project to the thalamus, 
hypothalamus and cortex. These fibres are involved in the emotional 
dimension of pain (Shilo & Pascoe 2014). 
 
Perception 
Nociceptive information is integrated by the brain and the overall 
conscious and emotional experience of pain is perceived. Indeed, 
nociception activation per se does not necessarily result in pain (Muir & 
Woolf 2001), but is a basic sensory ability (Sneddon et al. 2014). The 
somatosensory cortex, insular, anterior cingulate cortex and prefrontal 
cortex and the thalamus are involved in pain perception.  
 
1.1.4 Pain modulation 
 
Primary/peripheral sensitization 
Local release of chemical mediators, the so called “inflammatory soup”, 
from primary afferent fibres and other cells increases pain sensitivity by 
decreasing the threshold for activation of nociceptors or by direct 
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activation of nociceptors (Farquhar-Smith 2007). These substances 
include hydrogen ions, adenosine triphosphate (ATP), bradykinin, 
prostaglandins, leukotrienes, etc. Nociceptors express ion channels for 
stimulus transduction and action potential generation. Peripheral 
sensitization consist in the modification of expression of these membrane 
proteins, such as Transient receptor potential cation channel subfamily V 
member 1 (TRPV1), tetrodotoxin-resistant voltage-gated sodium 
channel (TTX-r Na+ channel). The clinical consequence of peripheral 
sensitization is primary hyperalgesia consisting of an increase in the 
painfulness of a noxious stimulus and reduced threshold for pain at the 
site of tissue injury (Shilo & Pascoe 2014). 
 
Central sensitization 
Peripheral sensitization increases inputs from primary afferent neurons to 
the spinal cord. In the dorsal horn of the spinal cord amplification 
mechanisms enable the peripheral neurons that are not involved in 
nociception, to carry painful sensations (Shilo & Pascoe 2014). Secondary 
hyperalgesia is caused by central sensitization and consists in the 
production of pain by mechanical stimulation around the site of injury. 
Allodynia, that is to say pain caused by a stimulus that does not normally 
provoke pain is another manifestation of central sensitization. N-methyl-D-
aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
receptor (AMPA) receptors are involved in central sensitization and are 
activated by neuropeptides like substance P and calcitonin gene-related 
peptide (CGRP) (Farquhar-Smith 2007). 
 
Descending modulatory pathways 
Brainstem descending pathways can be either inhibitory (antinociceptive) 
or facilitatory (pronociceptive) and their activity contributes to the control of 
the output of second order neurons. 
Descending inhibitory fibres from the periaqueductal grey (PAG) in the 
midbrain and the rostral ventromedial medulla (RVM), project to the dorsal 
horn and inhibit pain transmission by utilizing monoaminergic 
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neurotransmitters such as noradrenaline and serotonin. Other 
neurotransmitters involved in the descending modulation of spinal 
nociceptive processing include opioids, GABA, cannabinoids and 
adenosine (Shilo & Pascoe 2014). 
 
“Gate control” theory of pain 
This theory proposed by Melzack and Wall describes a process of 
inhibitory pain modulation at the spinal cord level. Activation of Aβ fibres 
by tactile non noxious stimulation, activates inhibitory interneurons in the 
spinal cord, which inhibit pain signals transmitted via the C fibres (Melzack 
& Wall 1965).  
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1.2 Sheep: experimental model and farm animal 
 
The sheep (Ovis aries) is one of the most widely spread domestic animals 
and its domestication occurred about 9,000 years ago, in the Neolithic 
period, in the Fertile Crescent (Rocha et al. 2011). Due to their adaptability 
to extreme climatic conditions, nutrient poor diets and manageable size, 
sheep spread worldwide and they are raised for meat, milk, and wool. 
Nowadays sheep are also widely used in experimental research. 
 
1.2.1 Sheep: experimental model 
 
The origins of animal testing dates back to the Ancient Greek when 
physician such as Herophilus, Galen, Aristotle, Hippocrates had been 
using animals as models of their anatomy and physiology (Franco 2013). 
Advances in medicine, surgery, pharmacology and biomedical sciences, 
including the discovery of blood circulation, organ transplantation, 
achievements in immunology and genetics, formation of modelling 
methods and drug testing, were obtained through experimentation on 
animals. 
The selection of the animal model should be based on several factors 
including (Davidson et al. 1987): 
- appropriateness as an analog 
- transferability of information 
- genetic uniformity of organisms, where applicable 
- background knowledge of biological properties 
- cost and availability 
- generalisability of the results 
- ease of and adaptability to experimental manipulation 
- ecological consequences 
- ethical implications. 
The key factor in using animals in research is in the possibility of 
extrapolation of results to humans. Indeed translation of findings from the 
laboratory to clinical trials is not always straightforward and the type of 
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animal model is of fundamental importance (Perel et al. 2007). Sheep are 
considered as adequate models for several disciplines including 
orthopaedics, neurology, cardiology and internal medicine, because they 
closely correlate with human anatomy and physiology (Pearce et al. 2007; 
Potes et al. 2008; Guillamon & Clau 2010; Katz et al. 2011; Mageed et al. 
2013; DiVincenti et al. 2014). 
Sheep are widely used in experimental research due to their availability, 
temperament and body size, which allows easy handling, manipulation 
and access for sampling, monitoring and insertion or application of various 
devices. Moreover their anatomy and physiology has been widely studied 
so baseline data are available to scientists (Adams & McKinley 2009). 
Disadvantages of the use of sheep as experimental animals include the 
necessity of large animal facilities and equipment. 
The benefits to science and medicine, does not relieve the scientists from 
responsibility to guarantee animal welfare during the experiments. Indeed, 
current opinion is favourable to the use of animals in experimental 
research, when the advantage of using them surpass the inconvenience 
and provided that no other alternative exists and no unnecessary suffering 
occurs (Flecknell 2002). 
The basis for a more ethical use of animals in experimental settings were 
set by Russell and Burch in the late 1950s (Russell W.M.S. 1959). The 
3Rs theory consists of: replacement, reduction and refinement. According 
to the “replacement” principle “non-sentient” alternative methods, such as 
in vitro techniques or bioinformatic model, should be used instead of 
experimental animals whenever possible. “Reduction” to a minimum of the 
number of animals can be achieved by improving the experimental study 
design by setting standardized conditions and by performing an 
appropriate power analysis before commencing it (Festing & Altman 
2002). “Refinement” consists of alleviating pain and distress in animals as 
much as possible. As pain and distress may affect several physiological 
functions, safeguarding experimental animal’s welfare will be beneficial not 
only for the animal but for the experimental outcome as well (Baumans 
2005). 
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These principles have influenced new legislation aimed at controlling the 
use of experimental animals worldwide (Flecknell 2002). 
 
1.2.2 Sheep: farm animal 
 
Sheep were one of the first farmed animals, reared for meat, milk and 
wool. 
There are many concerns about sheep welfare in farms, related to 
management procedures, transport and illness caused by disease.  
Castration, dehorning, tail docking and mulesing (removal of skin from 
perineal area to prevent flystrike) are common husbandry procedures 
performed in farms, while lameness caused by infectious pododermatitis 
(footrot), mastitis, external myiasis and urolithiasis are common diseases 
affecting sheep (Scott 2007). It has been shown that these procedures 
and conditions cause pain and distress in sheep, which may be long 
lasting (Stafford 2014).  
Effective ways to alleviate pain and discomfort in farms animals are 
fundamental to ensure animal welfare. Indeed, according to the “Five 
freedoms” theory, animal welfare is based on “Freedom from pain, injury 
and disease”, together with “Freedom from hunger and thirst”, “Freedom 
from discomfort”, “ Freedom to express normal behaviour” and “Freedom 
from Fear and Distress” (FAWC 1993). 
By analogy with the “3Rs” approach of “Replacement, Reduction and 
Refinement”, in order to minimise pain in farm animals, other authors have 
developed the “3S” theory accounting for “Suppress, Substitute and 
Soothe”. According to this theory, any source of pain for which negative 
effects outweigh potential benefits for the animal should be suppressed. 
Methods that have been proven to be more painful should be substituted 
with less painful ones. Finally, whenever the animal is experiencing pain 
treatments should be used to soothe it (Guatteo et al. 2012). 
Provision of analgesia in animals is fundamental not only for ethical 
reasons but also because untreated pain may lead to significant economic 
losses, in terms of decreased productivity (Paul-Murphy et al. 2004). 
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1.3 Pain recognition and assessment in sheep 
 
1.3.1 Pain recognition in animals 
 
One of the pillars on which animal welfare is based is the recognition and 
proper treatment of pain (Rutherford 2002). Accurate pain assessment in 
the individual animal allows adequate analgesic treatment and avoids the 
changes in peripheral and central nervous system which may lead to 
primary and secondary hyperalgesia allodynia and spontaneous pain. 
Once peripheral and central sensitization has occurred, control of pain 
becomes more difficult to achieve (Woolf & Salter 2000). This is not only a 
theoretical concept, but something that animals experience in their 
lifetime; indeed it has been shown that some of the procedures normally 
carried out on farms in very young animals cause a lasting state of 
somatosensory sensitization (Vinuela-Fernandez et al. 2007). 
In human pain assessment, self-reporting plays a fundamental role, but 
self-report is not possible in small children, handicapped or elderly people, 
who are unable to speak or have cognitive dysfunction (von Baeyer 2009; 
Hadjistavropoulos et al. 2014). The same problem applies to animals 
which cannot verbalise their suffering and report the sensations they are 
experiencing (Anand & Craig 1996). 
There is a clear need for valid and reliable tools to assess pain in animals 
in order to allow effective pain recognition in experimental and clinical 
settings (Crook 2014). 
Several methods are available to recognise and measure pain in animals, 
but no gold standard exists. The ideal method should be specific, 
sensitive, reliable and valid and the assessment should be comprehensive 
and practical (Kent & Molony). 
Pain assessment can be performed using objective or subjective methods, 
as described by Kent & Molony (Kent & Molony) and by Crook (Crook 
2014). 
 
Pain can be recognised using the following different measures: 
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Physiological parameters:  
- Measurement of heart rate, blood pressure, respiratory rate and 
temperature; assessment of pupillary dilation, sweating, defecation, 
urination; measurement of general bodily functions (food and water 
intake, etc.) or productivity (weight gain, milk production, etc.) 
 
- Neurohumoral responses: plasma or salivary cortisol, catecholamines, 
glucose, endorphins 
- Biochemical responses: plasma glucose, free fatty acids, lactic acid, 
acute phase proteins (APP) 
 
Neurophysiological parameters: 
- Changes in the electroencephalogram (EEG) activity: changes in the 
frequency of EEG can be considered as marked of nociception 
 
Behavioural observations: 
- Behavioural responses: introduction of new abnormal behaviours, 
decreased frequency of normal behaviours. These changes may 
comprise changes in gait, posture, vocalization, facial expression, 
activity, mental status, evoked behaviours and behavioural patterns. 
 
Quantification of pain is based on: 
Nociceptive threshold testing:  
- the threshold at which a subject responds to a noxious stimuli applied 
to the body is measured 
 
Pain scales:  
- several pain scales have been developed, such as the visual analogue 
rating scale (VAS), simple descriptive scale (SDS), numerical rating 
system scale (NRS) or multi-dimensional/composite scales. 
 
Methods developed to recognise and quantify pain in animals have been 
shown to have advantages and disadvantages. 
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Physiological parameters are easily obtained and provide objective 
measurements but are not sensitive and specific methods for pain 
detection and have been shown to be inconsistent (Auer et al. 2007). 
Many stressors other than pain may activate the sympatho-adrenal and 
hypothalamic-pituitary-adrenal system, including eating, exercise, noise 
and drug administration (Kent & Molony; Rutherford 2002). The same 
considerations apply to biochemical and neurohumoral parameters, which 
have not been proven to provide a practical application yet, as other 
stressors may alter their concentration in the body, including diseases and 
drug administration (Kent & Molony; Rutherford 2002). 
Both physiological and biochemical/neurohumoral parameters are 
subjected to individual variabilities and to changes due to circadian 
rhythms; moreover they are invasive methods, as a blood sample is 
usually required, and handling itself can alter them (Kent & Molony). For 
these reasons their clinical use is of little importance (Holton et al. 1998). 
Weight gain and speed of wound healing are only crude parameters for 
assessing pain and they lack of sensitivity and specificity (Stafford 2014). 
Some difficulties may arise when assessing behavioural signs of pain; for 
example, some changes in posture can be involuntary and caused by 
spinal and brainstem reflexes.  
When using pain scales, the training of the assessor plays a fundamental 
role. The VAS, SDS and NRS are considered to be unidimensional scales 
and measure principally the intensity of pain. In multidimensional scales 
more parameters likely to be indicative of the emotional effects of pain are 
considered.  
The VAS scale consists of a 100mm long line; where 0mm is considered 
to be no pain and 100mm the worst possible pain imaginable or the worst 
possible pain for the procedure performed. The assessor marks the line at 
the point which they think represents the degree of pain that the animal is 
experiencing. The score is the distance, in mm, along the line from the 
zero anchor to the line marked by the assessor.  
SDSs are very easy to use and simple and the assessor selects one of a 
small number of descriptors. NRSs are discontinuous scales, where 
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descriptors of pain are assigned numbers. Multidimensional pain scales 
usually integrate objective and subjective behavioural observations. 
As pain scoring using scales is subjective, problems concerning intra and 
inter-observer variability may arise (Holton et al. 1998); some scales have 
been shown to be more sensitive than others, an example is the use of 
VAS over NRS in sheep (Welsh et al. 1993). Unidimensional pain scales 
do not consider pain in its multidimensional expressions, involving the 
sensory and affective components. Composite pain scales provide a more 
complete view of the pain the animal is experiencing but may be more 
time consuming to complete. Nociceptive threshold tests are based on 
stimuli that are different from clinical pain and they do not take into 
account the emotional dimension of pain. 
 
Nowadays pain assessment in animals is based on measurement of 
physiological and behavioural indices (Rutherford 2002). Knowledge of the 
behavioural repertoire of the individual species is mandatory to identify 
signs of pain. Behavioural changes can be considered as the animal’s way 
to self-report pain. 
 
1.3.2 Pain assessment in sheep 
 
Pain assessment in sheep lags behind progress made in the field in other 
species including small animals, horses and rodents. In other species 
including dogs (Reid et al. 2007), cats (Brondani et al. 2013), rodents 
(Langford et al. 2010; Sotocinal et al. 2011), horses (Dalla Costa et al. 
2014), cattle (de Oliveira et al. 2014) pain scales have been designed and 
validated and they constitute a reliable and practical method to assess 
pain in clinical environments. 
Pain recognition in ruminants is difficult; they are prey species and as such 
there was a strong evolutionary pressure to mask signs of pain as 
predators could likely detect these as indicators of weakness (Stafford 
2014). Another reason for masking pain could be that adult ruminants 
have no advantage to show pain as other adult conspecifics would not 
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assist or help them (Stafford 2014). This is particularly true for sheep, 
which tend to remain silent during painful procedures, unlike goats and 
cattle, vocalisation is shown only in case of very severe pain (Stafford 
2014). This does not mean that sheep do not feel pain; indeed, in sheep 
many medical conditions and standard husbandry procedures that are 
carried out on farms are a source of pain, such as lameness, caused by 
footrot or abscess, myiasis, tail docking, castration, dehorning, tail docking 
and mulesing (Scott 2007). 
Several methods have been used to recognise and evaluate pain in sheep 
including, physiological, biochemical, neurohumoral parameters, 
behavioural and EEG changes. 
As commented before, physiological and neurohumoral parameters may 
be altered by handling itself, so researchers have also been looking for 
non-invasive methods of pain assessment via the use of telemetry 
(Stubsjoen et al. 2009).  
Table 1.1 shows the studies evaluation pain in sheep. 
 
 
 
19 
 
Table 1.1 Studies evaluating pain in sheep classified by parameters used to identify it. 
 Physiological / Neurohumoral / Biochemical parameters 
(Shutt et al. 1988) Lambs undergoing castration (rubber ring or surgery) plus docking showed a significant increase in 
beta-endorphins and cortisol. Surgery caused less distress than the application of rubber ring. 
(Ley et al. 1991) Sheep suffering from severe lameness showed increased plasma prolactin and decreased plasma 
cortisol concentrations, while plasma vasopressin did not consistently change with lameness.  
(Kent et al. 1993) Lambs underwent castration by different methods and tail docking, changes in plasma cortisol 
between pre and post procedure corresponded to behavioural changes.  
(Ley et al. 1994) Plasma cortisol concentrations did not show any correlation with the severity of lameness in sheep.  
(Thornton & Waterman-
Pearson 1999) 
Several castration methods were assessed in lambs and they all caused an increase in cortisol 
(Price & Nolan 2001) In new-born lambs undergoing castration and tail docking haptoglobin levels were similar to control 
lambs.  
(Mellor et al. 2002) In lambs undergoing castration and tail docking a rapid increase in noradrenaline concentration and a 
marked increase in cortisol concentration were reported. No significant changes in adrenaline 
concentrations were shown. 
(Peers et al. 2002) In lambs undergoing castration and tail docking, BP and HR increased up to 4 hours after the 
procedure, while ACTH and cortisol increased markedly during the first hour, but returned to basal 
values by 2.5-3 hours. No significant changes in in mean plasma concentrations of renin, 
electrolytes, minerals, glucose, lactate, urea, creatinine, total carbon dioxide and total proteins were 
reported. 
(Stubsjoen et al. 2009) In sheep exposed to a noxious ischaemic stimulus heart rate variability was shown to be a sensitive 
non-invasive method to assess mild to moderate pain while changes in eye temperature measured 
using infrared thermography was a less sensitive method.  
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(Paull et al. 2007) Mulesed lambs showed increased plasma cortisol, reduced lying and increased standing with a 
hunched back compared with sham mulesed animals. A combination of local anaesthetic and long 
acting non-steroidal anti-inflammatory drug decreased the pain response of lambs to mulesing. 
(Paull et al. 2008) The effect of NSAIDs on mulesing in lambs was examined. In comparison to control lambs, mulesed 
lambs showed an increase in plasma cortisol, beta-endorphin and haptoglobin, decreased body 
weight and changes in behaviour including spending less time lying ventrally and walking but more 
time standing with a hunched posture. NSAIDs administered before mulesing did not reduce the 
acute response of lambs to mulesing. 
(Paull et al. 2009) The physiological (plasma cortisol and haptoglobin) and behavioural responses suggest that ring 
castration has less impact on the lamb than surgical castration. NSAIDS and topic local anaesthetic 
formulation provided modest improvement in pain and discomfort. 
(Paull et al. 2007) Mulesed lambs showed increased plasma cortisol, reduced lying and increased standing with a 
hunched back compared with sham mulesed animals. A combination of local anaesthetic and long 
acting non-steroidal anti-inflammatory drug decreased the pain response of lambs to mulesing. 
(Colditz et al. 2009) Non-surgical mulesing by injection of cetrimide in lambs caused increased rectal temperatures, 
cortisol, haptoglobin, decreased daily gain, abnormal behaviours including hunched standing, stiff 
walking, pawing, lateral lying and lying intention. Carprofen ameliorated the behavioural responses, 
but was unable to provide relief from the intense and sustained physiological responses to non-
surgical mulesing by intradermal injection of cetrimide. 
 Behavioural observations 
(Molony et al. 1993) Several methods of castration in lambs of different ages were examined and it was shown that all the 
methods caused quantitative and qualitative changes in behaviour. 
(Kent et al. 1993) Lambs underwent castration by different methods and tail docking, changes in plasma cortisol 
between pre and post procedure corresponded to behavioural changes.  
(Welsh et al. 1993) NRS and VAS were used for subjective assessment of lameness in sheep and they showed intra-
observer reproducibility, but more variation with sheep suffering from what was considered moderate 
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lameness. 
(Ley et al. 1994) Plasma cortisol concentrations did not show any correlation with the severity of lameness in sheep.  
(Kent et al. 1995) In lambs undergoing tail docking different methods of castration were assessed. Foot stamping, 
restlessness, tail flicking, abnormal postures, rolling and kicking were observed.  
(Lester et al. 1996) Abnormal standing and lying were noticed in lambs undergoing castration and tail docking by 
different methods.  
(Stafford et al. 1996) Aversive behaviours were shown in rams undergoing electroejaculation. 
(Thornton & Waterman-
Pearson 1999) 
In lambs undergoing castration by different methods, local anaesthetics abolished responses to 
rubber ring (RR) and combined rubber ring and Burdizzo clamp (CM), but did not affect the response 
to surgical castration (SX). General anaesthesia did not reduce responses to RR and SX but avoided 
the rise in MNT. 
(Thornton & Waterman-
Pearson 1999) 
VAS scale combined with active behaviours, response to an observer and response to scrotal 
palpation was used to compare the pain caused by a number of castration techniques with or without 
analgesia. 
(Dinniss et al. 1999) Restlessness was shown in lambs up to 4 hours after ring castration. Clamp castration did not 
causes restlessness. 
(Molony et al. 2002) Behaviours recorded in sheep during and after castration included restlessness, rolling, jumping, foot 
stamping/kicking, easing quarters, tail wagging, head turning, vocalization, lip curl, teat seeking, 
trembling, normal lying, abnormal lying (ventral or lateral), normal standing, statue standing (hind 
limbs apart, further back than normal), abnormal standing (unsteady, backward, on knees, hops, 
circling, leaning, falling). 
(Thornton & Waterman-
Pearson 2002) 
Several methods of castration were examined in lambs of different ages. Castration caused a 
reduction in time spent performing play behaviour in one week old lambs. In four to six week old 
lambs castration caused a decrease in lying behaviour and an increase in abnormal postures. 
Behavioural changes were present for 3 days post castration.  
(Paull et al. 2007) Mulesed lambs showed increased plasma cortisol, reduced lying and increased standing with a 
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 hunched back compared with sham mulesed animals. A combination of local anaesthetic and long 
acting NSAID decreased the pain response of lambs to mulesing. 
(Paull et al. 2008) The effect of NSAIDs on mulesing in lambs was examined. In comparison to control lambs, mulesed 
lambs showed an increase in plasma cortisol, beta-endorphin and haptoglobin, decreased body 
weight and changes in behaviour including spending less time in lying ventrally and walking but more 
time standing with a hunched posture. NSAID administered before the procedure did not reduce 
acute response of lambs to mulesing. 
(Paull et al. 2009) The physiological (plasma cortisol and haptoglobin) and behavioural responses suggested that ring 
castration has less impact on the lamb than surgical castration. NSAIDS and topic local anaesthetic 
formulation provided modest improvement in pain and discomfort. 
(Lomax et al. 2008) In lambs undergoing mulesing, topical anaesthesia decreased pain-related behaviour and improved 
wound healing.  
(Lomax et al. 2010) Topical anaesthesia alleviated the short-term pain of castration and tail docking in lambs according to 
behavioural observations and mechanical nociceptive threshold testing. 
(Lomax et al. 2013) In lambs undergoing mulesing, local anaesthetics decreased primary and secondary hyperalgesia 
and pain-related behaviours and provided analgesia for up to 24 hrs.  
 Electrophysiological parameters 
(Morris et al. 1997) Painful electrical stimulation in sheep caused changes in EEG, which can be considered a useful tool 
to measure acute pain in these species. 
(Ong et al. 1997) Electrical stimulation was applied to sheep being implanted EEG electrodes. According to 
electroencephalogram changes recorded, this method could provide a measure of acute pain in this 
species. 
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The first studies performed evaluated husbandry procedures commonly 
carried out on farms without the use of analgesics, such as castration, 
mulesing and dehorning. The behaviour, physiological, biochemical and 
neurohumoral parameters of sheep undergoing painful procedures have 
been compared to sham controls or to themselves before the procedure 
(Paull et al 2007 & 2008). The findings of these early studies constitute the 
bases of pain assessment in sheep. Moreover, research focused also on 
the impact of different surgical methods and the choice of some 
procedural techniques over others was suggested and was then 
introduced into practice (Shitt et al 1988, Kent et al. 1993 & 1995, Molony 
et al. 1993). Finally, newly identified indicators of pain could be used to 
compare the efficacy of different drugs (Colditz et al 2009). Several 
studies included more than one type of assessment, such as evaluation of 
physiological parameters, neurohumoral/biochemical essays, observation 
of behaviours, response to observer, response to wound palpation, and 
measurement of pain by the use of subjective pain scales and nociceptive 
tests (Thornton & Waterman-Pearson 1999). 
These studies showed that changes in plasma cortisol values are useful in 
assessing pain of moderate intensity but not severe pain, as a ceiling 
effect was reported. (Kent et al. 1993; Molony et al. 2002). Moreover 
changes in plasma cortisol values during chronic pain may not be 
consistent (Ley et al. 1991; Ley et al. 1994). Acute phase proteins were 
not reliable indicators of pain in lambs (Price & Nolan 2001).  
Normal postures and gaits have been described in lambs (Molony et al. 
1993; Molony et al. 2002) and this helped with the recognition of abnormal 
behaviours in sheep after painful procedures (Kent et al. 1995; Molony et 
al. 2002). Pain scoring scales have been used to evaluate lameness in 
sheep and the VAS was more sensitive than the NRS (Welsh et al. 1993). 
Nociceptive threshold tests were used to assess hyperalgesia in sheep 
undergoing painful procedures (Lomax et al. 2010; Lomax et al. 2013). 
Measurement of electrophysiological parameters can be potentially useful 
in pain recognition, but more research is necessary in this field and its 
practical use would be difficult. 
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Behavioural assessment of pain is recognised to be one of the most 
specific and sensitive ways of assessing pain in farm animal species 
(Molony & Kent 1997). Many studies have evaluated behavioural changes 
associated with painful procedures. Behavioural indicators of pain in 
sheep are shown in table 1.2. 
The expression of pain through behaviour may include suppression or 
change in frequency of common behaviours as well as introduction of new 
behaviours indicative of pain. In summary, a high variability in behaviours 
has been shown which depends on the kind of procedure performed and 
the age of the animal. The most obvious behaviours such as vocalization 
and aggression after palpation of the affected area were reported only 
after very painful procedures. Moderate pain caused changes in postures, 
gait, eating and sleeping patterns. Sedation, illness or stress may affect 
short term behavioural observations and twenty four hours, or longer, 
monitoring period is required to detect changes in patterns of behaviour. 
 
Table 1.2. Behavioural indicators of pain in sheep. 
 
Behavioural indicators of pain in sheep 
   
Inappetence Restlessness Abnormal lying 
Isolation Rolling Abnormal standing 
Inactivity Jumping Abnormal postures 
Decreased play Head turning Foot stamping 
Aggression  Trebling Easing quarters 
Vocalization (severe pain only) Lip licking Itching quarters 
Colic signs Teeth grinding Kicking 
Dull expression Tail flicking Wound licking 
 
Sources: (Kent & Molony; Kent et al. 1995; Molony & Kent 1997; Hardie 2000; Thornton 
& Waterman-Pearson 2002; Stafford 2014) 
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In conclusion, a combination of physiological and behavioural indices are 
useful for recognising and assessing pain in sheep, but they have shown a 
high variability according to the type of procedure performed and age of 
the animals. 
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1.4 Nociceptive threshold testing 
 
1.4.1 Quantification of pain: nociceptive threshold testing 
 
Animals cannot self-report the level of pain they are experiencing, and as 
explained before, neurohumoral/biochemical and electrophysiological 
parameters are not specific indicators of pain (Le Bars et al. 2001). Pain 
assessment in animals relies mainly on behavioural observations, and 
thus the importance of knowing each species behavioural repertoire in 
order to detect abnormal behaviours, which may be indicative of pain. 
Animal’s pain scoring is subjective and affected by the assessor’s 
observational skills, attitudes towards pain and knowledge of the species’ 
ethogram (Hardie 2000). In order to overcome the subjectivity of the 
scoring which is implied in the observational method, a more objective way 
to quantify the degree of pain experienced by the animal consists in the 
measurement of nociceptive thresholds. The term “ nociception” originates 
from the Latin “ nocere” which means “ to harm” and was first introduced in 
the early 1990s (Sherrington 1910). Nociception consists in the detection 
of potentially harmful stimuli, and in conscious animals gives rise to pain, 
which has both a sensory and emotional component (Sneddon 2004). 
Nociceptive systems have developed and become more complex during 
evolution; they have been extensively studied in vertebrates and recent 
studies have shown the presence of nociceptors in lower vertebrates too 
(Sneddon 2004). 
Nociceptors are specialised peripheral sensory neurons which are 
activated by potentially damaging stimuli at the skin, mucosa, deep fascia, 
connective tissue of visceral organs, ligaments and articular capsules, 
periosteum, muscles, tendons and arterial vessels (Almeida et al. 2004). 
Nociceptors transduce these stimuli into electrical signals conveyed to 
higher brain centres (Dubin & Patapoutian 2010). Thermal, mechanical, 
chemical stimuli, with the potential to injure tissues, activate functionally 
distinct cutaneous nociceptors and the variety of receptors involved is 
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mirrored by the multiple characteristics of pain (Dubin & Patapoutian 
2010). 
Nociceptors are associated with free nerve endings and represent the 
more distal part of first-order neurons; the classification of first order 
afferent neuron fibres in terms of structure, diameter and conduction 
velocity is shown in table 1.3. 
Nociceptors are generally electrically silent; once stimulated they transmit 
an action potential. Perception of pain does not directly come from their 
activation but peripheral inputs have to be transmitted to and modulated 
by higher centres (Dubin & Patapoutian 2010). 
 
Nociceptive threshold testing (NTT), also referred to as Quantitative 
Sensory Testing (QST), are used in experimental and clinical settings in 
people (Rolke et al. 2006; Arendt-Nielsen & Yarnitsky 2009; Backonja et 
al. 2013; Grosen et al. 2013; Hubscher et al. 2013). NTT has also been 
widely used in the veterinary experimental research in studies evaluating 
the efficacy of analgesic drugs and in dose-finding studies (Love et al. 
2011), and to assess the neural processing of noxious stimuli (Hothersall 
et al. 2011). 
Many nociceptive stimuli have been used in research, including electrical, 
thermal, mechanical and chemical stimuli. As commented by Le Bars (Le 
Bars et al. 2001), studies carried out in conscious animals are referred to 
as “ behavioural studies” and this terminology implies that “all responses, 
including simple withdrawal reflexes, are part of an animal’s behaviour 
repertoire”. Nociceptive tests comprise an input, the stimulus applied, and 
an output, the reaction of the animals to that stimulus (Le Bars et al. 
2001). Nociceptive stimulation should be repeatable, reliable, quantifiable, 
with a clear end point non-invasive, and produce no harm to the animal 
(Beecher 1957). 
The stimulus variables include intensity, duration and surface area of 
stimulation: “these three parameters determine the global quantity of 
nociceptive information that will be carried to the central nervous system 
by the peripheral nervous system” (Le Bars et al. 2001). Other variables 
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when performing nociceptive threshold test include the site on the body 
where the stimulus is applied and the status of the site, if healthy or 
inflamed (Le Bars et al. 2001). Tests based on the use of short duration 
stimuli and long duration stimuli as referred as “phasic pain” and “tonic 
pain” experiments respectively (Le Bars et al. 2001). 
Limitations of NTT is that they provide a stimulation which is different from 
clinical pain, and in order to reproduce a stimulation as similar as possible 
to clinical pain more than one threshold testing modality should be used 
(Tyers 1980; Nielsen et al. 2009). That is the reason why these tests may 
not be sensitive enough to assess the analgesic properties of drugs in 
clinical settings (Love et al. 2011). 
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Table 1.3 Classification of first-order afferent fibres in mammals. [Adapted from (Almeida et al. 2004)] 
 
Fibre type 
 
Diameter Conduction velocity Structure Stimuli Comments 
      
Aβ >10 µm 30-100 m/sec Myelinated Respond to innocuous mechanical 
Stimulation. 
Do not propagate noxious 
stimuli in normal situations.  
Involved in segmental 
suppression of pain. 
 
Aδ 2-6 µm 12-30 m/ sec Barely myelinated Type 1: High threshold 
mechanoreceptors responding to 
high intensity mechanical stimuli and 
weakly to thermal and chemical 
stimuli and, after sensitization to 
harmful heat. 
Type 2: Mechano-termal receptors 
responding to very high and low 
temperatures. Later sensitization to 
vigorous mechanical stimuli at non-
noxious thresholds. 
 
Propagate information with 
marked intensity and short 
latency. Promote quick 
sensation and withdrawal 
actions. 
 
C 0.4-1.2 µm 0.5-2 m/sec Unmyelinated Polymodal receptors responding to 
mechanical, thermal and chemical 
stimuli. 
Silent receptors activated by 
inflammation 
Propagate information slower 
and their prolonged potentials 
undergo summation along 
time, and pain is felt as “dull” 
 
 
 
 
30 
 
1.4.2 Classification of nociceptive stimulation 
 
Electrical stimulation 
Application of an electrical stimuli has been used to test nociceptive 
withdrawals reflex in people and it has been proven to be a useful tool in 
pain assessment and research in central sensitization and chronic pain. It 
has also been used and validated in several species (Spadavecchia et al. 
2004; Bergadano et al. 2007) including sheep (Rohrbach et al. 2014; 
Rohrbach et al. 2015). The input given by the electrical stimulation is 
repeatable, controllable and non-invasive; nevertheless, it stimulates 
directly all peripheral fibres included the ones not involved in nociception 
and it is not a stimulus naturally encountered by an animal, and as such 
does not reflect clinical pain (Le Bars et al. 2001). Indeed it activates large 
diameter fibres not implicated in nociception and Aδ and C fibres which 
not only mediate nociception but also sensation of cold and hot (Le Bars et 
al. 2001). It can be considered as a non-invasive method to evaluate 
central sensitization as a consequence of surgery in animals (Rohrbach et 
al. 2015). 
 
Chemical stimulation 
Chemical stimuli are characterised by being progressive, slow form of 
stimulation whose effects are long lasting and inescapable (Le Bars et al. 
2001). This kind of stimulation differs greatly from the others not only 
because of the nature and duration but also because the output is not a 
threshold but a behavioural score (Le Bars et al. 2001). 
  
Thermal stimulation 
Thermal stimuli have been widely used in laboratory animals in a variety of 
test including the tail flick test, paw and tail withdrawal tests and hot plate 
tests (D’Amour & Smith 1941; Woolfe & Macdonald 1944; Luttinger 1985). 
These tests consists in either the application of a constant temperature 
and measurement of the time taken for the animal to respond (latency), or 
the application of ramped increasing temperatures and record of the 
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temperature at which the animal respond (threshold temperature) (Love et 
al. 2011). Heat stimulates thermosensitive and nociceptive fibres and so it 
stimulates cutaneous receptors in a more selective way (Le Bars et al. 
2001). Thermal stimulation can be conveyed by radiant heat sources, 
thermode based systems or carbon dioxide laser thermal stimulators (Le 
Bars et al. 2001). Thermal nociceptive threshold has been use to evaluate 
the analgesic/antihyperalgesic effect of drugs and the nociceptive 
processing in horses (Dhanjal et al. 2009; Hoffmann et al. 2012; Love et 
al. 2012; McGowan et al. 2013; Poller et al. 2013), dogs (Hoffmann et al. 
2012), cats (Slingsby et al. 2010; Slingsby et al. 2012; Ambros & Duke 
2013; Farnworth et al. 2015), birds (Caplen et al. 2013; Hothersall et al. 
2014) and sheep (Nolan et al. 1987a; Nolan et al. 1987b; Nolan et al. 
1987c; Nolan et al. 1988). Thermal nociceptive tests performed using 
radiant heat have the advantage that the source is not directly in contact 
with the skin, but, on the other hand, measurements are affected by the 
radiation (reflectance, transmittance, absorbance), conduction properties 
and the initial temperature of the skin (Le Bars et al. 2001). Thermodes 
have the disadvantage of activating both nociceptors and low-threshold 
non –nociceptive nerves exerting inhibitory influences on pain 
mechanisms (Le Bars et al. 2001). In the past their use in animals was 
limited due to their fixed and rigid surface and the difficulty in 
standardization of skin contact pressure (Le Bars et al. 2001), but this 
disadvantage has been overcame as new probes have been designed 
specifically for animals, and the pressure at which the probe contacts the 
skin can be modified (Dixon et al. 2002; Love et al. 2011). Moreover a 
wireless thermal threshold testing system has been used in horses (Love 
et al. 2011). The carbon dioxide laser thermal stimulator overcomes the 
disadvantaged of the other thermal nociceptive threshold devices (Le Bars 
et al. 2001), and only recently its use has been investigated in veterinary 
medicine (Farnworth et al. 2013). Thermal threshold temperatures varies 
between and within the species and they are affected by skin 
pigmentation, hair density, skin thickness and composition, depth and 
density of Aδ and C fibre nociceptors within the tissue (Love et al. 2011; 
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Grint et al. 2015). Fluctuations in ambient temperature and rate of heating 
may also affects thermal threshold (Love et al. 2011). One disadvantage 
of assessing thermal nociceptive threshold in species which do not clearly 
show behavioural pain expression, is the potential for skin lesions; to 
prevent it a thermal cut off is usually set. Nevertheless there are reports of 
thermal injuries in horses (Robertson et al. 2005), sheep (Musk et al. 
2014), and donkeys (Grint et al. 2015). In order to prevent burns, 
modifications to a thermal probe used in animals have been recently done 
(Dixon et al. 2015). 
 
Mechanical stimulation 
A rudimental form of mechanical stimulation used in practice is 
represented by hoof testers (Love et al. 2011). Von Frey filaments were 
the first type of mechanical stimulus used in research but they do not 
provide a specific noxious stimulation, as they activates both low threshold 
mechanoreceptors and nociceptors; difficulty in application to unrestrained 
animals also apply (Le Bars et al. 2001). Nowadays they are used in 
rodents to measure mechanical thresholds and in larger species to identify 
allodynia (Taylor & Dixon 2012b).  
Several veterinary research and clinical experimental studies evaluated 
and validated the use of mechanical nociceptive threshold (MNT) devices 
in order to measure the level of pain after a procedure or to quantify the 
analgesic or antihyperagesic effect of a drug in several species including 
cats (Dixon et al. 2007; Bortolami et al. 2013), dogs (Dixon et al. 2010; 
Hunt et al. 2013), horses (Love et al. 2012), donkeys (Grint et al. 2014), 
cattle (Whay et al. 1997; Raundal et al. 2014), birds (Hothersall et al. 
2011), pigs (Nalon et al. 2013), sheep (Nolan et al. 1987a; Nolan et al. 
1987b; Lizarraga & Chambers 2006; Lizarraga et al. 2008) and rodents 
(Callahan et al. 2008). Measurement of mechanical nociceptive threshold 
is useful tool to assess pain in clinical conditions as well; this test can be 
considered a proper adjunct to clinical care, that is why in the United 
Kingdom this method can be used in practices without Home Office 
License (Jolliffe et al. 2009). 
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Mechanical nociceptive threshold tests can evaluate both somatic and 
visceral sensory systems.  
Somatic MNT testing devices consists in a probe which is applied to the 
skin of the test area and an increasing force, usually generated by a 
pneumatic cylinder, is exerted to this probe until a clear response is 
evoked. The reflex withdrawal which is the first reaction seen can be 
considered as a spinal reflex, but then the animal can exhibit signs which 
involve supraspinal structures, such as escape behaviours and 
vocalization (Le Bars et al. 2001). 
The dorsal aspect of the limb is the area mainly used in large animal 
species for MNT tests (Nolan et al. 1987a; Whay et al. 1997; Love et al. 
2012), because of minimum amount of soft tissue present in that area and 
the minimal anatomical variations (Love et al. 2011). MNT values have 
been found to differ significantly between different anatomical locations in 
some species (Haussler & Erb 2006; Harris et al. 2015).  
Both hand-held (Nolan et al. 1987a; Whay et al. 1997; Haussler & Erb 
2006; Stubsjoen et al. 2010; Raundal et al. 2014) and limb-mounted 
mechanical algometers have been used (Love et al. 2012; Nalon et al. 
2013; Musk et al. 2014) in large animal species. Hand held algometers 
allow measurement of thresholds on multiple body sites (Stubsjoen et al. 
2010), and do not require restraint of animals and are useful when working 
with animals kept in loose-housing systems (Raundal et al. 2014) but the 
animals see the operator approaching it and so there is a higher 
predictability of the stimulus (Nalon et al. 2013). Limb-mounted 
mechanical algometers have the advantage of being operated remotely 
from the animal, thus preventing distraction or anxiety which may affect 
the result of the test (Taylor et al. 2015). Moreover limb actuators are 
usually securely strapped to the limb thus preventing slippage as observed 
when using a hand-held probe (Nalon et al. 2013). A dummy device can 
also be fitted to the contralateral limb so that the animal is not distracted 
by uneven balance (Nolan et al. 1988) 
Another variable when using MNT devices is the probe design. In people 
probes with tips of different sizes are used to differentiate the origin of 
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pain; in animals it has been shown that MNT increases with tip diameter 
and that large tip diameters produced more variability in MNTs (Taylor & 
Dixon 2012b; Raundal et al. 2014; Taylor et al. 2015). It has also been 
shown that MNT values are not proportional to the area of the probe tip, 
but a relationship was shown with the square root of the probe tip diameter 
(Taylor & Dixon 2012a).  
A three pin configuration tip was designed, and used in some studies, in 
order to maintain better contact by preventing the probe from angling and 
sliding off the limb, but it was proven to provide more variable data (Taylor 
et al. 2015). In order to avoid the animal’s reactions when the probe first 
makes contact with the skin, a spring loaded configuration, which 
maintains the probe in contact with the skin at 1-2 N, has been evaluated 
in sheep and horses, but the results are controversial (Musk et al. 2014; 
Taylor et al. 2015). 
Several other factors influence the results of nociceptive threshold testing, 
such as skin thickness, coat density, gender, distractions, exposure to new 
ambient, disruption of social bounds. Marked variations in ambient 
temperature should be avoided because they may affect equipment 
performances and alter skin perfusion (Love et al. 2011). The assessor’s 
experience, handling of the animal, rate of stimulus application may also 
affect the test results. 
Finally, after prolong testing, animals may develop a sort of habituation to 
the procedure, with the consequent decrease in MNT values over time 
(Stubsjoen et al. 2010) or manifest a learned response, that is to say that 
the animal respond to the stimulus as soon as it is perceived rather than 
when or becomes aversive (Love et al. 2011)  
In conclusion, nowadays there is no gold standard method or device for 
measuring MNT in any species (Taylor et al. 2015). The type of device, 
the probe configuration (dimensions, shape, profile), the area tested 
(thickness, coat, different innervation, soft tissue), the rate of stimulus 
application, but also ambient temperature, age of animals, companion 
status, distractions, exposure to new environment are factor which may 
account for the variability of data reported in the studies (Taylor et al. 
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2015). For these reasons these factors have to be specified when 
reporting an experiment (Taylor et al. 2015). 
 
1.4.3 Nociceptive threshold testing in sheep 
 
Quantitative sensory testing methods have been used in conscious painful 
and non-painful (naïve) sheep in order to assess the efficacy of analgesic 
drugs, including opioids (Nolan et al. 1988; Waterman et al. 1991a; Kyles 
et al. 1993b), non-steroidal anti-inflammatory drugs (NSAIDs) (Welsh & 
Nolan 1994; Welsh & Nolan 1995b) ,α2-adrenergic agonists (Grant et al. 
2001; Grant & Upton 2004), local anaesthetics (Lomax et al. 2008) and to 
assess hyperalgesia caused by husbandry procedures or pathological 
conditions (Ley et al. 1989; Welsh & Nolan 1995a). Both hand held 
algometers (Stubsjoen et al. 2010) and limb actuators have been used in 
this species (Nolan et al. 1987a; Chambers et al. 1994). Thanks to these 
studies the site of action of analgesic drugs was assessed (Brandt & 
Livingston 1990; Waterman et al. 1991b; Kyles et al. 1993a; Kyles et al. 
1993b; Lizarraga & Chambers 2006). 
Ambient temperature below 8˚C caused a marked decrease in thresholds 
(Chambers et al. 1994). In sheep kept for experimental use MNT values 
were less variable than the one measured from naïve sheep (Welsh & 
Nolan 1995b). 
Species differences in the number and distribution of opioid receptors may 
account for the different activity of drugs, thus the different effect of opioid 
in different species (Nolan et al. 1987c) and different class of opioid may 
have more effective at suppressing thermally induced nociception than 
mechanical induced (Waterman et al. 1990). Finally breed can have an 
impact on the efficacy of analgesic drugs due to different metabolic 
pathways (Ley et al. 1990). 
Table 1.4 shows the studies performed in sheep using a mechanical 
nociceptive threshold device. 
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In the study performed by the Author in chapter 4, a limb mounted 
mechanical nociceptive threshold device comprising a cuff with a 2 mm 
hemispheric blunt pin fixed on a rolling diaphragm actuator and applied 
perpendicular to the skin of the test area. The pin was pushed against the 
skin of the dorsal aspect of the right metacarpus, approximately 4 cm 
below the carpus, with a force which was applied manually by a syringe, 
connected to non-distensible tubing via a digital meter which displayed the 
force exerted, until a clear withdrawal response (leg lift, head turn, weight 
bearing on the contra-lateral limb) was evoked. The force at which the 
sheep responded with a clear withdrawal response was recorded as the 
MNT. As suggested by previous studies (Chambers et al. 1994), sheep 
were penned individually in specially designed pens, which allowed them 
to move without turning round, and the assessor to access their legs. 
Moreover sheep could be in visual and auditory contact with other usual 
flock mates, a measure recommended to limit stress in experimental 
sheep (Livingston et al. 1992). Sheep have been acclimatised to the 
environment, assessors and to the MNT test, as acclimatization and 
training have been shown to reduce the variability of the results (Welsh & 
Nolan 1995b). In order to avoid distractions, the same level of ambient 
noise was maintained constant during the experiments. 
 
In conclusion, the measurement of nociceptive thresholds can be used to 
provide evidence that the animal is experiencing pain, to evaluate the 
analgesic/antihyperalgesic properties of drugs and to assess 
hypersensitization and correlate it with clinical conditions (Ashley et al. 
2005).  
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Table 1.4. Studies performed in sheep using a mechanical nociceptive threshold device. 
(Nolan et al. 1987a) Reliable series of values for thermal and mechanical nociceptive thresholds tests were obtained. 
(Nolan et al. 1987c) Buprenorphine (3 and 6 µg/kg IV) showed no detectable mechanical antinociception. Prior treatment with 
naloxone (0.2 mg/kg IV) did not affect the response threshold. Subsequent injection of xylazine (50 µg/kg IV) 
increased the threshold to maximum. Buprenorphine showed thermal mechanical antinociception which was 
detectable up to 3 and ½ hours. 
(Nolan et al. 1987b) Xylazine (50µg/kg IV) caused an immediate increase of MNT to maximum value of 16 N, values returned to 
basal levels after 45 min. Clonidine (6µg/kg IV) increased threshold to maximum within 3 minutes at it remained 
like that for 45 min, reaching control values after 120 min. Prior administration of idazoxan (0.1 mg/kg IV) 
abolished the effects of both xylazine and clonidine, while naloxone (0.2 mg/kg IV) did not. MNT markedly 
increased with both xylazine and clonidine. 
(Nolan et al. 1988) Pethidine (5 mg/kg IV) produced a significant degree of antinociception to thermal pain for 30 min (on average) 
but gave only a few minutes of significant analgesia when tested with the mechanical pressure system.  
(Waterman et al. 1988) Intrathecal injections of small volumes of the α2-adrenoceptor agonists, xylazine (5-50 µg) and clonidine (100µ), 
into the cervical region of the spinal cord of conscious unrestrained sheep produced a dose-dependent analgesia 
of the forelimbs as measured using a mechanical pressure device. Intravenous injection of the α2-adrenoceptor 
antagonist, idazoxan completely abolished the analgesic effects of the intrathecally applied α2-adrenoceptor 
agonists. 
(Ley et al. 1989) Chronic pain from footrot in sheep caused a reduction in the threshold to mechanical pressure, with thresholds 
remaining lower for periods longer than 3 weeks in many cases, with some returning normal after 3 months. 
Footrot did not alter the threshold to the thermal test. 
(Waterman et al. 1990) After fentanyl (5 µg/kg IV) administration significant analgesia to thermal pain was reported for 30 minutes but 
mechanic antinociceptive activity was not detected. However fentanyl at a dose rate of 10 µg/kg produced both 
thermal (60 min) and mechanical (40 min) antinociceptive effects.  
 
 
 
 
38 
 
(Kyles et al. 1990) Intrathecal administration of naloxone (5 mg) caused significant mechanical hyperalgesia. 
(Ley et al. 1990) Antinociceptive effects of xylazine administered intravenously varied with the breed of the sheep tested. 
(Waterman et al. 1991a) Butorphanol (0.05, 0.1, 0.2, 0.4 mg/kg IV) produced dose-dependent thermal antinociception, but no significant 
elevation in mechanical pressure threshold.  
(Waterman et al. 1991b) Buprenorphine (1.5, 12 µg/kg IV) caused significant increase in thermal threshold for 40 minutes, but no 
mechanical antinociception. 
(Ley et al. 1991) Intensity and duration of analgesia produced by xylazine (50 µg/kg IV) was significantly reduced in animals 
experiencing chronic pain (footrot). When the test was repeated after clinical resolution of the condition there was 
almost no change in the profile of the chronic pain animals with MNT values being significantly different from the 
controls. 
(Kyles et al. 1993a) Intrathecal xylazine (100 µg/kg) increased mechanical nociceptive thresholds in the sheep; this effects was 
abolished by prior intrathecal administration of a selective α2-adrenoceptor antagonist. 
(Kyles et al. 1993b) Droperidol (5 µg/kg IV) combined with fentanyl (5 µg/kg IV) and zuclopenthixol (100µg/kg IV) combined with 
fentanyl (5 µg/kg IV) increased significantly MNT. 
(Chambers et al. 1994) Further development in the design of a MNT device was made. The device showed normal distribution of 
thresholds in both healthy and lame sheep; the mean threshold in lame sheep was slightly but significantly lower 
than that in healthy sheep. 
(Welsh & Nolan 1994) The tourniquet was placed on the sheep limb and it significantly decreased MNT values in the ipsilateral limb, but 
not in the contralateral. Pre-treatment flunixin (1 mg/kg IV) or carprofen (0.7 mg/kg IV) attenuated the 
development of mechanical hyperalgesia, and fentanyl (5 µg/kg IV) caused significant antinociceptive effects 
initially. 
(Welsh & Nolan 1995a) Abdominal surgery caused thermal hyperalgesia in the acute post-operative period, similar changes were not 
found with mechanical stimulation. 
(Welsh & Nolan 1995b) Lame sheep did show lower MNT values than healthy (non-experimental) sheep; but MNT values was 
significantly greater than that recorded from experimental animals. Flunixin (1or 2 mg/kg IV) had no effect on 
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 MNT in either lame or healthy sheep but its repeated administration to lame sheep reduced their thresholds to 
noxious mechanical stimulation. 
(Ley et al. 1995) Sheep suffering from severe lameness showed lower mechanical threshold values than their matched sound 
controls and their thresholds remained low when tested three months later, after the apparent resolution of the 
foot rot lesion. In flocks where lame sheep were less severely affected there was no difference in the threshold 
responses to a mechanical stimulus between the sound and lame sheep. 
(Chambers et al. 1995) Flunixin (2.2 mg/kg IV) and dipyrone (25 mg/kg IV) caused a small but statistically significant rise in mechanical 
pain thresholds. In the lame sheep a similar effect occurred but the response was smaller, much more variable 
and tended to be prolonged. Pre-treatment with naloxone or atipamezole prevented the rise in thresholds. 
Naloxone and atipamezole had no effect on thresholds when given alone to healthy sheep. 
(Lizarraga & Chambers 
2006) 
Intrathecal cumulative concentrations (0.375–200 µM; 100 µL) of ketoprofen, phenylbutazone, salicylic acid and 
tolfenamic acid as well as a single IV dose (3, 8, 10 and 2 mg/kg, respectively) of each NSAID were administered 
to sheep. None of the NSAIDs administered by the intrathecal route increased MNT values, while only IV 
ketoprofen and tolfenamic acid raised the pain thresholds. The hypoalgesic effect of IV ketoprofen was 
prevented by intrathecal naloxone or atipamezole. 
(Lizarraga et al. 2008) In sheep, intrathecal administration of ketoprofen (200-3200 µM; 100 µL) and ketamine (25-400 µM; 100 µL), 
alone or in combination, produced no hypoalgesia; however, they prevented NMDA-induced mechanical 
hypersensitivity. 
(Stubsjoen et al. 2010) An electronic hand-held algometer, provided with a blunt plastic tip of 0.5 cm2, was tested and proven useful to 
measure MNT in sheep. A decrease in MNT values over 3 consecutive test days was reported. 
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1.5 Pain treatment in sheep 
 
Difficulty in pain treatment in animals arise from the difficulty in detecting 
pain-related behaviours, lack of cost-effective licensed analgesics, 
withdrawal times and fear of side effects (Valverde 2013). 
 
1.5.1 Opioids 
 
The use of opioids in sheep is not common due to issues related to 
licensing, schedule classification and fear of side effects. 
Opioid receptors are protein G-protein coupled receptors and once 
activated they promote a cellular signalling cascade leading to closure of 
voltage-sensitive calcium channels, efflux of potassium and reduction of 
cyclic adenosine monophosphate production. The result is a decrease in 
neuronal excitability through cellular hyperpolarization, inhibition of 
neurotransmitters release (Duke-Novakovski 2014). Different opioid 
receptors have been classified as µ, ƙ, δ and nociception/orphanin and 
they are located at spinal (substantia gelatinosa) and supraspinal 
(periaqueductal grey area, amygdala, corpus striatum, hypothalamus) 
sites (Duke-Novakovski 2014). 
The efficacy of opioids in sheep has been proven mainly in experimental 
settings. An increase in thermal nociceptive threshold values was 
observed with buprenorphine (Nolan et al. 1987c; Waterman et al. 1991b), 
pethidine (Nolan et al. 1988), fentanyl (Waterman et al. 1990) and 
butorphanol (Waterman et al. 1991a), while an increase in mechanical 
threshold values was detected only with fentanyl (Waterman et al. 1990) 
and pethidine (Nolan et al. 1988). 
There are limited studies assessing the administration of opioids in 
anaesthetised sheep; it has been shown that opioids exert anaesthetic -
sparing effects: oxymorphone and hydromorphone significantly decreased 
minimum alveolar concentration (MAC) of desflurane by more than 7% 
(Sayre et al. 2015), while, an infusion of fentanyl (10µg/kg/h) decreased 
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MAC of isoflurane by more than 22% (Funes et al. 2015). The analgesic 
effects of fentanyl administered transdermally in a clinical experimental 
setting seemed promising (Ahern et al. 2009; Christou et al. 2015). 
Nevertheless, an infusion of fentanyl has been shown to cause respiratory 
depression in sheep undergoing cardiac surgery (Kronen et al. 2005). 
Other experimental studies tested the effects of opioids in sheep to 
evaluate their possible analgesic properties, physiological effects or 
adverse events in preclinical models (Booke et al. 1996; Upton et al. 1997; 
Swenson et al. 1998; Smith et al. 2004). The epidural administration of 
opioids was shown to be useful as part of the analgesic management of 
procedures on flank and hind limb. (DeRossi et al. 2015).  
 
1.5.2 Tramadol 
 
The main side effects of opioid therapy in people are nausea, vomiting, 
sedation, drowsiness, dizziness and cardiovascular and respiratory 
depression, urinary retention, constipation, miosis; other disadvantages 
are potential for abuse and dependency (Candiotti & Gitlin 2010). 
Research has focused on the synthesis of analgesic drugs with good 
analgesic efficacy but devoid of undesirable side effects (Giorgi 2012).  
Tramadol seems a promising analgesic drug because although it is has 
been shown to have analgesic properties similar to other opioid agonist 
drugs, it was shown to minimally affect the respiratory, cardiovascular, and 
gastro-intestinal system and has minimal potential for misuse or 
dependency. Moreover tramadol is not a controlled drug or scheduled 
analgesic in most countries and this facilitates its access and use (Bonezzi 
2008). For these reasons the pharmacokinetics and antinociceptive effect 
of this drug were evaluated in sheep by the Author. 
 
Tramadol is a centrally acting synthetic analgesic drug structurally related 
to codeine and morphine; tramadol is 6000-times less potent than 
morphine and 10-times less potent than codeine (Vazzana et al. 2015).  
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Tramadol has shown a dual mechanism of action which results in the 
inhibition of both perception and transmission of pain (Mattia & Coluzzi 
2005). 
Noradrenaline and serotonin reuptake inhibition are predominantly caused 
by (-) and (+) enantiomers of the parent compound respectively, while the 
(+) enantiomer of O-desmethyltramadol and to a lesser extent (+) tramadol 
activates the µ opioid receptors (Grond & Sablotzki 2004). 
In people, the active metabolite, O-desmethyltramadol (M1) has an affinity 
for the μ opioid receptor 300 times higher than that of the parental drug 
and its analgesic efficacy seems to be 6 times higher than that of the 
parent compound (Gillen et al. 2000). 
In humans tramadol provides good analgesia with only mild effects on 
cardio-respiratory function and intestinal motility (Raffa et al. 1992) and is 
not a scheduled drug. 
In people therapeutic serum concentrations of tramadol and M1 were 0.3 ± 
0.2 to 590 ± 410 ng/ml and 0.08 ± 0.03 µg/ml respectively (Lehmann et al. 
1990; Grond et al. 1999). The minimum effective concentration showed a 
wide variability between subjects due to genetic polymorphisms which 
affect tramadol metabolism (Pedersen et al. 2006). 
 
Tramadol in veterinary medicine 
The pharmacokinetics and biotransformation of tramadol have been 
studied in several animal species including the dog, cat, goat, llama, 
alpaca, horse and donkey (KuKanich & Papich 2004; Giorgi et al. 2007; de 
Sousa et al. 2008; Pypendop & Ilkiw 2008; Giorgi et al. 2009b; Cox et al. 
2011; Stewart et al. 2011; Edmondson et al. 2012). Species-specific 
differences in the kinetic profiles of both the parent drug and its 
metabolites have been highlighted. 
Tramadol was shown to have analgesic effects in dogs and cats 
undergoing surgical procedures (Kongara et al. 2013; Morgaz et al. 2013; 
Teixeira et al. 2013; Evangelista et al. 2014) 
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There are also studies confirming the analgesic efficacy of tramadol for the 
management of peri-operative pain in other ruminants (Bigham et al. 2010; 
Habibian et al. 2011; Dehkordi et al. 2012). 
 
1.5.3 Alpha-2 adrenoceptor agonist drugs 
 
Alpha2-adrenoceptor agonist drugs are widely used in sheep because of 
their analgesic and sedative effects, nevertheless their effect is short 
lasting and they are not devoid of side effects, including cardiorespiratory 
depression, alteration of ventilator parameters leading to hypoxaemia, and 
increased myometrium tone (Kastner 2006; Kastner et al. 2007).  
Adrenergic receptors are protein G-coupled receptors, are targeted by 
catecholamines and are present in many tissues including peripheral and 
central nervous system. Analgesic and antihyperalgesic effects are 
caused by activation of the descending noradrenergic-serotoninergic 
inhibitory pain pathway, while sedation is due to activation of receptors in 
the pontine locus coeruleus and which decrease activity of ascending 
neural projections to the cerebral cortex and limbic system (Seddighi 
2014). 
Analgesic activities of systemically administered α2-adrenergic agonists 
has been proven by experimental pain models using nociceptive testing 
and by clinical experimental studies (Grant et al. 1996; Grant et al. 2001; 
Grant & Upton 2001b; Grant & Upton 2001a; Hughan et al. 2001; Grant & 
Upton 2004). Analgesic effect, onset and duration of action depend on 
dose and route of administration; analgesia was proven to be generally 
short lasting, approximately 60-90 minutes (Nolan et al. 1987b; Grant & 
Upton 2001a; Grant & Upton 2004). 
The neuraxial administration of α2-adrenergic agonists has been 
extensively investigated not only in the experimental but also in the 
practical setting (Waterman et al. 1988; Aminkov & Hubenov 1995; Scott 
et al. 1995; Scott & Gessert 1997a; Scott & Gessert 1997b; Vesal & 
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Oloumi 1998; Christina Haerdi-Landerer et al. 2005; Rostami & Vesal 
2012). 
 
1.5.4 Nonsteroidal anti-inflammatory drugs 
 
Nonsteroidal anti-inflammatory drugs (NSAIDs) have anti-inflammatory, 
anti-nociceptive, anti-pyretic, anti-endotoxemic and anti-neoplastic 
properties. 
Briefly, NSAIDs inhibit the production of inflammatory mediators 
synthetized from arachidonic acid, by the activation of lipoxygenase and 
cyclooxygenase, such as leukotrienes, thromboxanes and prostaglandins 
(Clark-Price 2014). 
Their mechanism of action, pharmacokinetics, and analgesics effects after 
surgical procedures have been widely studied in sheep (Cheng et al. 
1998; Landoni et al. 1999; Arifah et al. 2001; Price & Nolan 2001; Ali 2003; 
Lizarraga & Chambers 2006; Paull et al. 2007; Paull et al. 2008; Colditz et 
al. 2009; Stock et al. 2013). NSAIDs have also been proven to be effective 
analgesics in cases of chronic pain (Welsh & Nolan 1995b). 
Several NSAIDs are licensed for use in cattle, provide cost-effective 
analgesia of medium duration; for these reasons they are one of the most 
popular analgesics administered to sheep.  
 
1.5.5 Local anaesthetics 
 
Local and regional anaesthetic techniques are widely used in sheep; 
market authorization of different local anaesthetics varies from country; in 
general the most used local anaesthetics include lidocaine, mepivacaine 
and bupivacaine. The onset and offset of action, adverse effects and 
analgesic effects depend on the drug used.  
Local anaesthetics cause reversible blockage of action potentials in 
sensory, motor and sympathetic fibres by blocking sodium channels and 
thus preventing depolarization of nociceptors (Lemke 2014). 
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Local anaesthetics are usually employed in neuraxial anaesthesia or are 
used for local infiltrations or peripheral nerve blocks (Vesal & Oloumi 
1998; Ratajczak-Enselme et al. 2007; Habibian et al. 2011; DeRossi et al. 
2012b; Rostami & Vesal 2012; DeRossi et al. 2015). 
 
1.5.6 Dissociative anaesthetics 
 
Ketamine is the most commonly used dissociative anaesthetic, and it is 
considered as a nontraditional analgesic agent, which has shown 
analgesic properties at subanaesthetic doses. It exerts antagonist action 
at the N-methyl-D-aspartate (NMDA) receptors, which are located in the 
brain and spinal cord and contribute to the development of hyperalgesia 
and central sensitization (Love & Thompson 2014).  
Systemic administration of ketamine is used in sheep mainly for induction 
and maintenance of anaesthesia (Lin et al. 1993; Lin et al. 1994; Hughan 
et al. 2001; Ozkan et al. 2010; Raske et al. 2010; Walsh et al. 2012). The 
use of ketamine in neuraxial techniques has been also investigated 
(Guedes et al. 2006; Lizarraga et al. 2008). 
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1.6 AIMS OF THE THESIS 
 
The studies described in this thesis were designed to evaluate 
administration of analgesics in sheep both in the experimental and in the 
clinical setting. 
The first study consisted in a meta-analysis of the reported use of 
analgesics in sheep used for experimental purposes in 2008, 2011 and 
2014. 
The second study was a questionnaire evaluating the current attitudes of 
Italian practitioners on pain assessment and treatment in sheep. 
Pain assessment and treatment in sheep lags behind progress made in 
the field in other species and there is paucity of data regarding 
pharmacokinetics and pharmacodynamics of analgesic drugs and limited 
number of drugs licensed for use in this species. Because of the 
favourable properties of tramadol reported in other species, the third study 
evaluated the pharmacokinetics and antinociceptive effect of tramadol and 
its metabolite O-desmethyltramadol (M1) in sheep in a preclinical model of 
pain. 
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Chapter 2 
 
REPORTED ANALGESIC ADMINISTRATION 
TO SHEEP UNDERGOING EXPERIMENTAL 
SURGICAL PROCEDURES 
______________________ 
 
2.1 Introduction 
 
Sheep are widely used as experimental models because their anatomy 
and physiology is similar to humans, they are easy to handle, clinical 
procedures are easy to perform after an appropriate training and there are 
less ethical concerns than the use of other animals (Turner 2007; Potes et 
al. 2008; Guillamon & Clau 2010; DiVincenti et al. 2014).  
In the last decades there has been an increasing interest in the welfare of 
animals used for scientific purposes and scientists have to comply with 
guidelines on their accommodation, care and use (Forbes et al. 2007; 
Anonymous 2011).  
Some of the requirements include the use of appropriate sedation, 
anaesthesia and analgesia together with the provision of adequate 
veterinary care (Anonymous 2011). Provision of anaesthesia and 
analgesia is important not only for ethical reasons but also because pain 
can cause neurohumoral changes which might potentially interfere with 
the aims of the study, thus confounding and affecting the research study‘s 
outcomes (Flecknell 2008). Indeed, it has been shown that uncontrolled 
perioperative pain may cause hypertension, myocardial ischemia and poor 
wound healing, just to list some complications, and may lead to central 
and peripheral neural sensitization (Vadivelu et al. 2010). 
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Currently in both human and veterinary medicine, an analgesic 
“multimodal” approach is recommended (Corletto 2007; Gritsenko et al. 
2014). Conventional analgesic drug classes include opioids, non-steroidal 
anti-inflammatories (NSAIDs) and local anaesthetics, but also α2-
adrenoceptors agonists and dissociative anaesthetics have analgesic 
properties. The use of different classes of drugs allow targeting pain along 
various pathways involving transduction, transmission, modulation and 
perception by the central nervous system (Gritsenko et al. 2014). 
A recent survey evaluating analgesic administration in 2000-2001 and 
2005-2006 has shown that “large” laboratory animals including sheep are 
more likely to receive pain relief in comparison to laboratory rodents, but 
provision of analgesia is still suboptimal (Coulter et al, 2009). 
The current study can be considered as a continuation of the work 
previously done by researchers from Newcastle University. A literature 
review was carried out in order to assess the reported use of analgesics in 
experimental sheep in the years 2008, 2011 and 2014. 
 
2.2 Materials and methods 
 
Search strategy 
Studies involving experimental procedures in sheep were identified using 
Scopus search engine (www.scopus.com), which was accessed from 
December 2014 to January 2015. The key words “sheep” and “surgery” 
were used. Original research papers published in English in 2008, 2011 
and 2014 and available as full text in electronic format at the University of 
Padua were selected. Whenever the inclusion criteria were met (described 
below), a random number generator was used to select 25 papers from 
each time period. 
 
Inclusion criteria 
Inclusion criteria were similar to the ones described by Coulter and 
colleagues (Coulter et al, 2009). Papers describing experimental 
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procedures carried out in sheep under general anaesthetic including a 
minimum of 24 hours recovery period were selected. 
 
Exclusion criteria 
Exclusion criteria were similar to the ones described by Coulter and 
colleagues (Coulter et al, 2009). Papers describing/evaluating a) multiple 
studies on different species of animals, b) foetal surgery, c) procedures 
carried out in neonatal lambs or pregnant sheep, d) neuropathic models of 
pain, e) analgesic efficacy of drugs, , f) changes of anaesthetic protocol 
during the course of the experiment, g) only one animal, h) material and 
methods not in detail, i) similar studies from the same research groups, j) 
review articles, letters to the editor, case reports and meta-analysis were 
excluded. 
 
Classification 
Experimental procedures were classified using similar criteria used by 
Coulter (Coulter et al., 2009) and Richardson (Richardson & Flecknell 
2005), but were modified as some procedures that are commonly 
performed in other species are not carried out in sheep. Classification 
included: thoracotomies, orthopaedic surgeries, neurological surgeries, 
maxillofacial surgeries, soft tissue surgeries, vascular surgeries, and other 
procedures.  
The procedure described in the paper was classified based on the most 
invasive procedure when either multiple procedures were described in one 
paper or when the study was carried out in two different time periods (e.g. 
experimental induction of infarction followed by its treatment days later). 
Analgesic and anaesthetic drugs used in the papers were classified as 
previously done by Coulter (Coulter et al., 2009). Opioids and non-
steroidal anti-inflammatory drugs were considered as systemic analgesic 
agents (SAA). Dissociative anaesthetic agents and α2-adrenoceptors 
agonists were considered as anaesthetic agents with analgesic properties 
(AAAP). Preanaesthetic medications (i.e. acepromazine) and anaesthetic 
agents without analgesic properties (i.e. propofol, inhalant agents and 
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benzodiazepines) were classified as anaesthetics. The use of local 
anaesthetic (LA) was reported. 
Whenever specified in the paper the dose, duration, frequency of 
analgesic administration were noted. 
The number and gender of animals used in each study and the duration of 
the study was noted as well as the specification of institutional ethical 
committee authorization and country where approval was given. 
 
Statistical analysis  
Data analyses were performed using SAS statistical software (version 9.3, 
SAS Institute). The Chi-square test was used for all comparisons among 
years, except study size which was analysed between time periods using 
a non-parametric Kruskal-Wallis test. P values < 0.05 were deemed 
significant. 
 
2.3 Results 
 
A total of 75 papers were selected, 25 from each time period (2008-2011-
2014).  
The papers were published in the following 47 journals:  
American Journal of Roentgenology, Annals of Biomedical Engineering, 
ANZ Journal of Surgery, Archives of Cardiovascular Diseases, Artificial 
Organs, ASAIO Journal, Biomaterials, BioMed Research International, 
BMC Musculoskeletal Disorders, BMC Veterinary Research, Bone, Clinical 
Oral Implants Research, Cytokine, European Journal of Cardio-thoracic 
Surgery, European Spine Journal, Gene Therapy, Injury, International 
Journal of Cardiology, International Journal of Developmental 
Neuroscience, International Urogynecology Journal and Pelvic Floor 
Dysfunction, Journal of Biomechanics, Journal of Biomedical Materials 
Research - Part A, Journal of Bone and Joint Surgery - American Volume, 
Journal of Bone and Joint Surgery - Series A, Journal of Bone and Joint 
Surgery - Series B, Journal of Cardiac Failure, Journal of Clinical 
Neuroscience, Journal of Cranio-Maxillofacial Surgery, Journal of Heart 
 
 
 
 
51 
 
and Lung Transplantation, Journal of Interventional Cardiology, Journal of 
Materials Science: Materials in Medicine, Journal of Minimally Invasive 
Gynecology, Journal of Orthopaedic Research, Journal of Rehabilitation 
Research and Development, Journal of Surgical Research, Journal of the 
American College of Cardiology, Journal of Thoracic and Cardiovascular 
Surgery, Journal of Vascular Surgery, Knee Surgery, Sports 
Traumatology, Arthroscopy, Medical science monitor basic research, Oral 
and Maxillofacial Surgery, PLoS ONE, Small Ruminant Research, Spine, 
Surgical Endoscopy and Other Interventional Techniques, Translational 
Stroke Research, World Journal of Surgery. 
 
Study size 
The median, minimum and maximum number of sheep enrolled in each 
year can be visualised in Table 2.1. There was a statistically significant 
decrease in the median number of animals involved in surgical 
experimental procedures in 2014 compared to 2011 and 2008 (P = 0.01).  
 
Table 2.1. Median number of animals enrolled in each study (minimum, 
maximum “study size”) each year and in all years together. 
 
 2008 2011 2014 ALL YEARS 
NUMBER OF SHEEP     
Median 12 15 8 12 
Minimum 3 5 2 2 
Maximum 58 58 40 58 
 
Classification of experimental procedures 
The most commonly performed procedures in sheep were thoracotomies, 
orthopaedic procedures and neurosurgeries. Table 2.2 and Figure 2.1 and 
2.2 indicate the number of procedures in the time period selected. 
Thoracotomies were performed mainly in studies evaluating myocardial 
infarction, valvular bioprosthesis, ventricular assistance devices and 
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cardio-pulmonary bypass. Orthopaedic and neurosurgery studies’ aims 
were the assessment of new surgical techniques, biomaterials and grafts. 
 
Table 2.2. Number of papers included in the review classified by type of 
procedure performed and by year. All years includes years 2008, 2011 
and 2014.  
 
PROCEDURES /YEAR 2008 2011 2014 ALL YEARS 
Maxillofacial surgery 3 0 3 6 
Neurosurgery 4 5 1 10 
Orthopaedic surgery 9 8 7 24 
Other procedures 1 0 1 2 
Soft tissue surgery 1 2 3 6 
Thoracotomy 7 10 5 22 
Vascular surgery 0 0 5 5 
 
Figure 2.1. Number of papers included in the review classified by type of 
procedure performed and by year. 
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Figure 2.2. Number of papers included in the review classified by type of 
procedure performed in all years (2008+2011+2014). 
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Specification of Institutional Ethical Approval and Countries where the 
study was conducted 
Specification in the papers of Institutional Ethical Committee approval or 
compliance with Guidelines for the Use and Care of Laboratory Animals 
approval was noted. 
As shown in Table 2.3 there was an increase in the report of ethical 
approval in 2014 but this was not statistically significant (P = 0.15). 
 
Table 2.3. Specification in the paper of ethical approval or compliance with 
guidelines for use and care of laboratory animals. “N” refers to number of 
papers and % to percentage of papers. 
 2008 2011 2014 ALL YEARS 
 N 
papers 
% 
N 
papers 
% 
N 
papers 
% 
N 
papers 
% 
Ethical 
approval 
21 84 19 76 24 96 64 85 
Guidelines 1 4 2 8 1 4 4 5 
No ethical 
approval 
3 12 4 16 0 0 7 9 
 
 
 
 
54 
 
The country where the study was conducted according to the institution 
where the approval was granted was noted. The studies were more 
commonly performed in the United States followed by Germany and 
United Kingdom, as shown in Table 2.4.  
 
Table 2.4. Country where the research study was conducted and total 
number of paper published in all years (2008-2011-2014).  
 
COUNTRY Number of 
papers 
Country Number 
of papers 
United States of 
America 
19 Austria 2 
Germany 10 Belgium 2 
United Kingdom 7 Canada 2 
Australia 5 Iran 1 
Brazil 4 Ireland 1 
Italy 4 Korea 1 
Switzerland 4 New Zealand 1 
China 3 Spain 1 
France 3 The Netherlands 1 
Israel 3 Turkey 1 
 
Animal’s gender 
Sheep gender was noted when specified in the papers. Female animals 
were most commonly chosen as described in Table 2.5.  
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Table 2.5. Number of papers specifying animal gender classified by year. 
 2008 2011 2014 
NUMBER OF PAPERS SPECIFYING 
GENDER 
16/25 16/25 14/25 
Number of papers where female sheep 
were enrolled in the study 
14/16 9/16 13/14 
Number of papers where male sheep 
were enrolled in the study 
2/16 6/16 1/14 
Number of papers where female and 
male sheep were enrolled in the study 
0/16 1/16 0/14 
 
Duration of experiments 
Duration of experiments was noted when specified in the papers. When 
there were different end points, for example a group of animals was 
euthanized at 2 weeks and another at 4 weeks, the longest time point was 
considered as the end of the experiment. Table 2.6 shows the duration of 
experiment by procedure in all years considered (2008-2011-2014). 
 
Table 2.6. Experiment duration indicated in weeks classified by kind of 
procedures in all years considered (2008-2011-2014) 
 EXPERIMENT DURATION 
(weeks) 
 Median Range 
PROCEDURES   
Maxillofacial surgery  14 4-26 
Neuro-surgery 12 7-40 
Orthopaedic surgery 16 2-96 
Other procedures 24.5 <1-48 
Soft tissue surgery 9 <1-56 
Thoracotomy 9 <1-72 
Vascular surgery 16 2-36 
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Use of analgesics 
The perioperative use of analgesic drugs was noted when specified. This 
study shows that when all years are considered together (2008-2011-
2014) opioids, NSAIDs, local anaesthetics, dissociative agents and α2-
receptor agonists were administered in 37.3%, 38.6%, 14.6%, 42.6% and 
18.6% of the papers respectively. 
Table 2.7 shows the number of papers specifying the use of α2-
adrenoceptor agonists, dissociative agents, NSAIDs, local anaesthetics 
and opioids. There were no statistically significant differences in the use of 
each analgesic drug between the years, as indicated by the P value >0.05. 
When considering all 75 papers, the most commonly reported analgesics 
drugs were xylazine (18.6%), ketamine (40%) carprofen (13.3%), flunixin 
(12%), buprenorphine (14.6%), bupivacaine (8%) and lidocaine (5.3%) 
with respect to α2-adrenoceptors agonists, dissociatives, NSAIDs, opioids, 
and local anaesthetic drugs (data not shown). 
 
Table 2.7. Percentage of papers specifying the use of analgesic drugs and 
the relative percentage is reported classified by year. P value refers to the 
statistical difference between years. 
 
DRUGS / YEAR 2008 2011 2014 ALL 
YEARS 
P value 
α2- adrenergic agonists 20% 24% 12% 18.6% 0.54 
Dissociative anaesthetics 36% 52% 40% 42.6% 0.49 
Local Anaesthetics 20% 8% 16% 14.6% 0.74 
Opioids 28% 40% 44% 37.3% 0.47 
NSAIDs 32% 40% 44% 38.6% 0.60 
 
Range of doses reported  
When specified in individual papers the range of doses reported for drugs 
with analgesic properties is shown in table 2.8.  
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Table 2.8. Range of reported doses of analgesic drugs. 
 
DRUG 
DOSE RANGE 
(mg/kg) 
 DRUG 
DOSE 
RANGE 
(mg/kg) 
Xylazine 0.02-1.5  Aspirin 3 
Tiletamine-
Zolazepam 
4-4.4  Carprofen 1-4 
Ketamine 10-25  Dipyrone 20-25 
Buprenorphine 0.005-10  Flunixin 1-2.2 
Butorphanol 0.06-0.4  Ketoprofen 50 
Fentanyl 0.002-0.0025  Ketorolac 0.5 
Meperidine 2  Meloxicam 0.4 
Morphine  0.2  
Tolfenamic 
acid 
2 
Tramadol 2    
 
Duration of post-operative analgesia 
The duration of post-operative analgesia was noted when specified. When 
more than one class of analgesic was used in the post-operative period 
the longest duration of analgesia was noted. Table 2.9 shows the number 
of papers specifying the duration of post-operative analgesia classified by 
procedure in all years (2008-2011-2014). Table 2.10 shows the 
percentage of papers classified by year specifying the use of post-
operative analgesia. There were no differences in the duration of post-
operative analgesia between years (P= 0.49) 
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Table 2.9. Number of papers specifying the duration of post-operative 
analgesia classified by procedure in all years considered (2008-2011-
2014) 
PROCEDURES 
1 
day 
2 
days 
3 
days 
4-5 
days 
1 
week 
>1 
week 
Not 
specified 
Maxillofacial 
surgery 
 1 2    6 
Neuro-surgery   2 1 1  6 
Orthopaedic 
surgery 
1 1 4 5  2 11 
Other 
procedures 
 1     1 
Soft tissue 
surgery 
   1   5 
Thoracotomy  2 1 1  1 17 
Vascular 
surgery       5 
 
 
Table 2.10. Number and percentage of papers classified by year 
specifying the use of post-operative analgesia.  
POST-OPERATIVE ANALGESIA 2008 2011 2014 ALL 
YEARS 
Number of papers indicating post-
operative analgesia 
11 9 7 27 
Percentage of papers indicating 
post-operative analgesia 
44% 36% 28% 36% 
Minimum days of post-operative 
analgesia 
1 2 2 1 
Maximum days of post-operative 
analgesia 
5 30 10 30 
Median days of post-operative 
analgesia 
3 5 3 3 
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Multimodal analgesia 
The reported use of analgesic drugs was noted. Analgesic drugs were 
classified as systemic analgesics agents (opioids and NDSAIDs), 
anaesthetic agents with analgesic properties (dissociatives and α2-
adrenergic agonists) and local anaesthetics. The use of these 3 classes of 
analgesics was investigated. The use of analgesics drugs was not 
statistically significant between year (P>0.05). Systemic analgesic agents 
were used in 53% of all 75 papers, a combination of systemic analgesic 
agents and anaesthetic agents with analgesic properties was reported in 
33.3% of the papers and only 8% of the paper reported the use of 3 
different classes of analgesics (Table 2.11). 
 
Table 2.11. Percentage of papers by years reporting the class of analgesic 
agents used.  
 
 
2008 2011 2014 
ALL 
YEARS 
P value 
SAA 48% 56% 56% 53.3% 0.8 
AAAP 44% 52% 44% 46.6% 0.8 
SAA + AAAP 28% 36% 36% 33.3% 0.78 
SAA + AAAP + LA 12% 4% 8% 8% 0.58 
Legend: SAA: systemic analgesic agents (opioids and NSAIDs), AAAP: anaesthetic 
agents with analgesic properties (α2- adrenoceptors agonists and dissociatives); LA: local 
anaesthetics. 
 
The analgesic multimodal approach was investigated by type of procedure 
(Table 2.12). When all years were considered together, systemic 
analgesic agents (opioids and NSAIDs) were given more often during 
neurosurgeries (78.3%), orthopaedic surgeries (59.3%) and thoracotomies 
(47.6%) than during other types of surgery. 
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Table 2.12. Reported use of systemic analgesic agents by year and by 
procedures. 
 
 
2.4 Discussion 
 
In this meta-analysis the reported use of analgesic agents in experimental 
sheep in 2008, 2011 and 2014 was assessed. Prior to clinical use in 
people, new biomaterials, drugs or surgical procedures often have to be 
tested in an animal model in order to test the biological responses and 
cellular interactions (Potes et al. 2008). Sheep are widely used as 
experimental models in many biomedical research fields, including 
orthopaedics, neurology, cardiology and internal medicine, due to 
physiological and anatomical similarities with the human body (Pearce et 
al. 2007; Potes et al. 2008; Guillamon & Clau 2010; Mageed et al. 2013; 
DiVincenti et al. 2014; Katz et al. 2015). 
Nowadays it is widely accepted that experimental animals should be 
provided with adequate analgesia not only for welfare and ethical 
considerations, but also because pain alters homeostasis and so could 
affect the end points of the research and thus become a source of 
experimental error (Anonymous 2011). Indeed pain causes changes in 
cardiovascular indices, ventilatory, renal and immunological functions, 
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coagulation parameters, behaviour and many other changes as described 
by Otto (Otto K.A. 1998). 
Guidelines regarding husbandry and anaesthetic/analgesic management 
have been designed for scientists (Forbes et al. 2007; Anonymous 2011) 
and the drugs used, the surgical procedure and the methods of euthanasia 
should be reported in the scientific paper (Kilkenny et al. 2010).  
One of the requirements for publication in some journals is declaration of 
approval by an ethical committee. In this study, specification of institutional 
ethical approval was noted and the number of papers reporting it 
increased in 2014 with 96% of papers indicating ethical approval, 
nevertheless the increase was not statistically significant. When all years 
were considered together the institutional ethical approval was specified in 
85% of the papers. 
This study has shown a statistically significant decrease in the number of 
sheep used in experimental research in 2014 in comparison to the 
previous years. Indeed the median number of animals decreased from 12 
and 15 in 2008 and 2011 to 8 in 2014. Data relative to years 2008 and 
2011 can be considered comparable to data obtained by Coulter and 
colleagues (Coulter et al. 2009), where the median number of sheep used 
in 2000-2001 and 2005-2006 were 15 and 12 respectively. Although these 
are not precise numbers relative to the number of sheep used for 
experimental purposes in the European Community (EU), a recent report 
showed a reduction of over half a million of all animals used in the EU 
from just above 12,0 million in 2008 to just under 11,5 million in 2011. 
Moreover ungulates represented the 1.4% and 1.2% of the total number of 
animals used in the Member States in 2008 and 2011 respectively 
(Anonymous 2013). So the trend found in the current study is in 
accordance with this EU report. 
A decreased number of animals used in research is one of the goals 
required by the Three R’s theory by Russell and Burch (Russell W.M.S. 
1959), which is considered to be a guiding principle for a more ethical use 
of experimental animals. The 3Rs theory asks for the replacement of the 
use of animals with alternative methods, the reduction of the number of 
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animals use in experimental studies and refinement of methods in order to 
alleviate pain and distress as much as possible. In particular, a reduction 
in the number of animals used in experimental research should be 
achieved by finding alternatives to animal use or by using other methods 
in order to obtain comparable levels of information from fewer animals, or 
to obtain more information from the same number of animals. Reduction of 
the number of animals focuses indeed on optimal experimental design 
with robust and appropriate statistical analysis including estimating the 
size of the experiment using power and sample size calculations (Festing 
& Altman 2002). 
This study showed that orthopaedic and neurological surgical procedures 
were the most commonly performed; original research papers were indeed 
classified by type of procedure and, when considering all years together 
(2008-2011-2016), 32% and 29% of papers describe orthopaedic and 
neurological surgeries respectively. These results are consistent with the 
ones reported in the previous study performed at Nottingham University 
(Coulter et al. 2009) where considering the studies published in two 
different time periods, 2000-2001 and 2005-2006, 26% and 43% of papers 
describe orthopaedic and neurological surgeries respectively. When 
considering the duration of the experiment, the longer lasting experiments 
involved vascular surgery, followed by orthopaedic and maxillofacial 
surgery. The expected level of pain after neurosurgery procedures, 
orthopaedic surgeries and thoracotomies can be considered very high and 
proper analgesia should be provided in the post-operative period. In this 
study, provision of post-operative analgesia was reported in 27 out of 75 
papers, and the duration was of 3 to 5 days in orthopaedic and 
neurological procedures and 2-4 days after thoracotomies. If we translate 
these procedures to small animals practice, in the author’s clinical 
experience analgesia is usually provided for at least one week: in the first 
48 hours postoperatively the use of full µ opioid agonists is suggested 
followed by partial µ agonist or other drugs such as tramadol or NSAIDs. 
In veterinary as well as in human medicine, a multimodal approach to 
analgesia is recommended: it implies the concurrent use of different 
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classes of analgesics, such as opioids, NSAIDs, local anaesthetics and α2-
adrenoceptors agonists and its aim is to decrease the doses and as a 
consequence the side effects of each single drug, while improving pain 
relief (Gritsenko et al. 2014; Mathews et al. 2014).  
When considered as all years together and all types of procedures, the 
reported use of multimodal analgesia was generally low, with only 8% of 
the papers reporting the use of systemic analgesics, anaesthetic agents 
with analgesic properties and local anaesthetics was reported. The fact 
that the analgesic regimen was not reported in the studies does not imply 
per se that pain relief was not administered to sheep; the goal of the vast 
majority of the papers was to describe new surgical techniques or 
therapies and so the anaesthetic regimen might have been overlooked. 
The analgesic plan should be not only multimodal but also “preventive”, 
which means that the analgesic drug should be administered before 
noxious stimulation thus preventing changes in the central nervous 
system, leading to central sensitization which manifests as allodynia and 
hyperalgesia (Katz et al. 2011). In the current study xylazine was 
administered preoperatively in 18.6% of papers. In sheep, xylazine 
induces dose dependent sedation and central nervous depression 
(Kastner 2006). Moreover α2-adrenoceptors agonists have analgesic 
properties (Yaksh 1979) and interact synergistically with opioid agonists 
(Drasner & Fields 1988). Xylazine is usually administered in conjunction 
with ketamine for induction of anaesthesia (Carroll & Hartsfield 1996); in 
this study ketamine was used in 40% of the papers. 
A drug can only manifest its analgesic effects when administered at the 
proper dose. Doses in sheep cannot be extrapolated from other species, 
as pharmacokinetic parameters, such as absorption, distribution, 
metabolism and excretion are species-specific, but there is paucity of data 
regarding pharmacokinetics and pharmacodynamics of analgesics in this 
species. Xylazine was used at doses between 0.02-1.5 mg/kg; the 
recommend dose of xylazine in sheep is 0.05-0.2 mg/kg (Valverde 2013), 
as higher doses could provoke marked side effects such as cardiovascular 
depression, alteration of ventilatory mechanics, hypoxia and pulmonary 
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oedema (Kastner 2006). Ketamine was used at doses ranging from 10 to 
25 mg/kg: suggested doses are 3-5 and 10-15 mg/kg for intravenous and 
intramuscular administration respectively (Riebold 2007). NSAIDs usually 
used in small ruminants are ketoprofen, flunixin, meloxicam, carprofen and 
tolfenamic acid (Hodgkinson 2007; Riebold 2007). Doses used in the 
selected papers were pretty similar to the ones suggested in textbooks, 
with some exceptions, such as ketoprofen. Doses reported for opioids in 
this study are similar to those reported in textbooks (Valverde 2013). 
Posology of analgesic administration was reported only in a few cases. 
Moreover in many cases the doses were not reported in the appropriate 
way (mg/kg) but as ml/animal or ml/kg without specification of the 
concentration of the drug administered. Moreover often the brand name 
was indicated and not the active principle; spelling mistakes have also 
been noted. Finally, none of papers described how pain was assessed 
post-operatively, and this is in agreement with previous reports (Coulter et 
al. 2009). 
The provision of adequate analgesia in experimental animals is one of the 
concepts included in the 3Rs’ theory; in particular refinement of methods 
consist also in avoiding or minimizing discomfort and pain (Russell W.M.S. 
1959). Pain treatment can be provided only if pain is recognised and 
assessed. If pain is not recognised it is unlikely to be treated. Recognition 
of pain may be difficult in sheep as they are prey animals and behavioural 
signs of pain may be subtle (Fitzpatrick 2006). Moreover a pain scale for 
sheep has not yet been designed; pain scales for rodents have been 
developed (Langford et al. 2010; Sotocinal et al. 2011) and have been 
used by scientists to assess the efficacy of post-operative analgesics 
(Matsumiya et al. 2012).  
 
2.5 Conclusions 
 
This study showed that the number of sheep involved in experimental 
research has decreased in 2014 compared with 2011 and 2008 and that 
anaesthetic and analgesic treatment is not properly reported in research 
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papers. The veterinary surgeon, or other trained professionals, should play 
an important role in the experimental research setting in recognising, 
assessing and treating pain adequately in animals used for scientific 
purposes.  
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Chapter 3 
 
ATTITUDES OF ITALIAN VETERINARIANS  
TO PAIN AND  
THE USE OF ANALGESICS IN SHEEP 
____________________________ 
 
3.1 Introduction 
 
“Freedom from pain, injury and disease”, one of the principles included in 
the “Five freedoms” theory (FAWC 1993) is one of the conditions required 
to ensure an animal’s welfare. Provision of analgesia in animals is 
fundamental not only for ethical reasons but also because untreated pain 
may lead to significant economic losses (Paul-Murphy et al. 2004). Pain 
recognition is mandatory to provide effective pain management, but 
recognising pain in sheep may be difficult as they are prey species and 
they tend to mask pain to their potential predators (Stafford 2014). The 
inability to appreciate signs of pain in cattle has led some practitioners to 
think that “farm animals are not as sensitive to pain as small animals” 
(Raekallio et al. 2003). In recent years research into pain assessment and 
recognition has increased and nowadays pain scales for detection of pain 
in dogs (Holton et al. 2001), cats (Brondani et al. 2013), horses (Dalla 
Costa et al. 2014) and cattle (de Oliveira et al. 2014) have been designed 
and are available to guide practitioners in pain treatment. Unfortunately a 
pain scale for assessment of pain in sheep has not yet been validated. In 
general, pain management in farm animals has not progressed as much 
as for small animals. Analgesic treatment in food producing animals is 
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particularly challenging due to the legal implications concerning 
prescription, record keeping, withdrawal times and lack of registered 
drugs. Nevertheless with the market authorization of α2-adrenoceptor 
agonist drugs and NSAIDs for use in cattle, more efficacious and longer 
lasting analgesia can be provided to this species (Stafford 2014). The risks 
of adverse effects, such as sedation by α2-adrenoceptor agonist or 
decreased ruminal motility by opioids may be another factor limiting the 
use of analgesics in ruminants. For the same reasons, analgesics were 
not administered to cats as often as in dogs (Capner et al. 1999), but 
thanks to research, market authorization of licensed drugs and teaching, 
feline pain management has improved massively in the last few years 
(Bortolami & Love 2015). Questionnaires regarding the practitioners’ 
attitudes towards pain and analgesics are important to assess changes in 
pain management over time, to address the research towards specific 
topics and to potentiate continuing education programmes. 
The aim of this study was to assess the attitudes of practicing sheep 
veterinarians working in Italy towards this topic. 
 
3.2 Materials and methods 
 
An on line questionnaire was designed based on other surveys previously 
carried out worldwide to investigate the use of analgesia in cattle (Huxley 
& Whay 2006; Laven et al. 2009; Thomsen et al. 2010; Lorena et al. 
2013). It was distributed to Italian veterinarians belonging to the Italian 
Society of Pathology and Breeding of small ovine and caprine species 
(SIPAOC) and SEMENTUSA project from April to June 2015. The 
questionnaire was sent on the behalf of the Department of Animal 
Medicine, Production and Health of the University of Padua and an e-mail 
accompanied the questionnaire explaining its aims, stating its anonymity 
and the estimated time (10 minutes) required to complete it. 
The questionnaire was divided into 5 sections: 
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- Section I concerned veterinarian’s demographic data and working 
activity, including gender, year of graduation, post-graduate degree 
obtained, working area, species treated, proportion of working time spent 
dealing with sheep. Information regarding flock characteristics, such as 
number of sheep and purpose (milk, meat, wool, mix, pet animals), were 
also asked. 
- Section II solicited information on provision of analgesia: drugs 
administered and anaesthetic techniques performed in the perioperative 
period (considered as 24 hours from the beginning of the procedure), or 
for specific medical conditions, including lameness, mastitis, and 
abscesses. Factors affecting drug choice, anaesthetic techniques used, 
use of non-pharmacological analgesic techniques were also investigated. 
- Section III investigated the drugs commonly used for specific procedures, 
such as castration, dehorning and caesarean section. 
- Section IV asked the veterinarian to rate the level of pain associated with 
specific surgical procedures or medical conditions, including castration, 
dehorning, caesarean section, fracture, lameness, abscess: a 10-point 
numerical rating scale was used, on which 1 represented no pain, and 10 
the worst possible pain. Veterinarians were asked to state which 
physiological and behavioural changes could be considered as indicators 
of pain in sheep and the reasons why provision of analgesia is not 
common in sheep. 
- Section V investigated the veterinarian’s opinion on their knowledge on 
the topic of sheep analgesia and which form of continuing education they 
would prefer to improve it. A copy of the questionnaire is included in the 
Annex A. 
 
Statistical analysis 
Data analyses were performed using SAS statistical software (version 9.3, 
SAS Institute). Chi-square test was used to compare the percentages 
between the different levels of the variables of interest, whereas non 
parametric Kruskal-Wallis test was used to compare pain scores. P values 
< 0.05 were deemed significant. 
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In order to be used in the data analysis, a questionnaire had to include all 
demographic data and 80% of the questions had to be answered. 
 
3.3 Results 
 
Section I. Demographic data 
A total of 31 questionnaires were returned, two of which were discarded as 
the veterinarians did not work with sheep, but only goats and cattle. The 
percentage of respondents cannot be calculated as the precise number of 
veterinarians who received the questionnaire was unknown, but it can be 
roughly estimated as 100-150 veterinarians.  
Of the respondents, 69% were male and 31% were female (Figure 3.1); 
44.8% and 55.2% of veterinarians graduated less and more than 10 years 
ago respectively (Figure 3.2). The vast majority of the veterinarians 
achieved a post graduate degree, with 3 people having more than one 
(Figure 3.3). Geographical distribution of veterinarians responding to the 
questionnaire is shown in figure 3.4. 
 
Figure 3.1. Gender of Italian veterinarians responding to the questionnaire. 
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Figure 3.2. Year of graduation of Italian veterinarians responding to the 
questionnaire. 
 
 
 
 
 
 
Figure 3.3. Post-graduation studies done by Italian veterinarians 
responding to the questionnaire.  
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Figure 3.4. Geographical distribution of working areas in Italy of 
veterinarians responding to the questionnaire. 
 
Only 10.35% of veterinarians worked only with sheep, while the greatest 
percentage, 38%, spent from 30 to 50% of their time treating sheep 
(Figure 3.5). 
 
Figure 3.5. Percentage of working time spent treating sheep by Italian 
veterinarians responding to the questionnaire. 
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Indeed, most of the respondents treated not only sheep but also other 
species, goats and cows in particular (Figure 3.6). 
 
Figure 3.6. Other species treated by Italian veterinarians responding to the 
questionnaire.  
 
 
Flock size and purpose are summarised in Table 3.1. 
 
Table 3.1. Size and purpose of flocks treated by Italian veterinarians 
responding to the questionnaire. 
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The level of association between the percentage of working time spent 
treating sheep and the flock size was found to be statistically significant 
(P=0.04): veterinarians who spent more time treating sheep dealt with 
bigger flocks (Data not shown). The level of association between the flock 
size and geographical area was investigated: it was found that bigger 
flocks are distributed in Southern Italy and Islands (P=0.02). 
 
Section II. Drugs used 
None of the veterinarians used opioids in sheep, not even in any particular 
circumstance. 
More than one half of veterinarians (51.8%) administer NSAIDs after the 
surgical procedure, while 31% do not usually administer them in the 
perioperative period (Figure 3.7). In case of lameness, mastitis, 
abscesses, 83%, 76% and 10% of veterinarians administer NSAIDs 
respectively (data not shown).  
 
Figure 3.7. Timing of perioperative NSAIDs administration. 
 
 
The two most commonly use NSAIDs were flunixin meglumine and 
ketoprofen (Figure 3.8).  
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Figure 3.8. Most commonly used NSAIDs by Italian veterinarians 
responding to the questionnaire. 
 
 
 
 
The most important factors affecting the choice of NSAIDs were efficacy, 
withholding time, veterinary market authorization, followed by costs, 
availability and safety profile (P=0.003) (Figure 3.9). 
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Figure 3.9. Factors influencing NSAIDs choice by Italian veterinarians 
responding to the questionnaire.  
 
 
 
Almost all veterinarians usually administer a local anaesthetic in the 
perioperative period (96.6%) and in particular after the surgery (96.6%); 
lidocaine was commonly used by all veterinarians (data not shown).  
Data regarding the use of local anaesthetic techniques can be visualised 
in figure 3.10: local infiltration was performed by most of veterinarians 
(89.7%), followed by epidural for abdominal/perineal procedures (69%), 
and intratesticular block (51.7%) (P<0.0001). When an epidural was 
performed, 86% of the veterinarians used a local anaesthetic only. 
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Figure 3.10. Local anaesthetic techniques performed in sheep by Italian 
veterinarians responding to the questionnaire. 
 
 
The association between the use of NSAIDs and local anaesthetic was 
investigated and although not statistically significant (P= 0.67), it was 
found that 68% veterinarians who administer NSAIDS administer also 
local anaesthetics, and 88.9% veterinarians who do not use NSAIDs 
administer a local anaesthetic peri-operatively. 
The association between the use of advanced local anaesthetic 
techniques, such as epidural anaesthesia, and the time of graduation and 
post-graduate education was investigated. 
When considering the year of graduation, before or after 2005, 56.2% and 
84.6% of veterinarians performed neuraxial anaesthesia respectively, but 
this was not found to be statistically significant (P=0.21). 
Of the veterinarians with a post graduate degree 80% performed 
epidurals, while 44.4% of veterinarians without a post graduate degree did 
not: this was not considered statistically significant (P=0.14). 
The most commonly used drugs in practice can be visualised in figure 
3.11. None of the veterinarians ever used tramadol in sheep. 
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Figure 3.11. Other drugs commonly used in the perioperative period by 
Italian veterinarians responding to the questionnaire. 
 
 
  
Section III. Drugs used for specific conditions 
- Castration and dehorning 
Local anaesthetics were commonly used for castration in sheep with 
41.6% of the veterinarians using them; a multimodal analgesic approach 
consisting of α2-adrenoceptor agonists, NSAIDs and local anaesthetics 
was used by 20.7% (Figure 3.12). The same multimodal approach was 
used only by 13.9% of veterinarians performing dehorning (Figure 3.13). 
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Figure 3.12. Most commonly used drugs for castration by Italian 
veterinarians responding to the questionnaire. 
 
 
 
 
Figure 3.13. Most commonly used drugs for dehorning by Italian 
veterinarians responding to the questionnaire. 
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-  
- Caesarean section 
There was a great variability among practitioners in drugs and techniques 
used for caesarean section; the number of classes of analgesic drugs 
used, classified as NSAIDs, dissociative anaesthetic agents and local 
anaesthetics, is shown in figure 3.14. Epidural anaesthesia alone or in 
combination with other drugs was performed by 55% of veterinarians. 
Multimodal analgesia with NSAIDs, α2-agonists and local anaesthetics 
was provided by 24% of veterinarians, while 34.5% of them used 2 
classes of analgesic drugs (from 2-agonists, NSAIDs, local anaesthetics, 
ketamine).  
 
 
Figure 3.14. Most commonly used drugs for caesarean section by Italian 
veterinarians responding to the questionnaire. 
 
 
 
Section IV. Estimated pain score 
Italian veterinarians responding to the questions regarding the pain 
experienced by sheep undergoing different surgical procedures or 
suffering from different conditions considered fracture to be the most 
3 classes of drugs (NSAIDs/ α-2 
agonist/Local … 
2 classes of drugs (NSAIDs/ α-2 
agonist/Local … 
1 class of drugs (Local 
anaesthetics) 
Do not perform caesarian 
sections/ None 
0 10 20 30 40 
D
ru
gs
 
Percentage of veterinarians 
 
 
 
 
81 
 
painful condition, followed by mastitis and lameness (P<0.0001) (Table 
3.2). 
 
Table 3.2. Estimated pain scores of Italian veterinarians responding to the 
questionnaire. Each cell shows the percentage of respondents who 
recorded that pain score; shaded cells show the mode. 
 
  ESTIMATED PAIN SCORE  
PROCEDURE 
/ CONDITION 
n 1 2 3 4 5 6 7 8 9 10 Median 
Castration 29 3.4 3.4 20.7 10.3 24.1 10.3 14 10.4 3.4 0 5 
Dehorning 29 0 6.9 14 20.7 17.2 6.9 10.3 17.2 3.4 3.4 5 
Caesarean 
Section 
29 0 10.3 13.8 10.3 10.3 10.3 24.1 14 6.9 0 6 
Fracture 29 0 0 0 6.9 10.4 10.4 17.2 17.2 17.2 20.7 8 
Mastitis 29 0 3.4 10.4 6.9 20.7 17.2 10.4 27.6 0 3.4 6 
Lameness 29 0 3.4 3.4 10.4 14 6.9 24.1 27.5 6.9 3.4 7 
Abscess 29 6.9 10.4 27.7 17.2 17.2 0 17.2 0 3.4 0 4 
 
The effect on pain scoring of year of graduation, gender and percentage of 
working time spent treating sheep was evaluated. Veterinarians who 
graduated before 2005 attributed higher median pain scores than the ones 
who graduated after 2005, with the median being 6 and 5 respectively (P= 
0.04). When all the conditions/procedures were considered together, the 
median pain scores attributed by female veterinarians was higher than 
males, with the median pain scores being 7 and 5 respectively (P<0.001). 
Nevertheless when the procedures/conditions were considered separately, 
a statistical significant difference was found only for lameness and 
caesarean section. No statistically significant difference was reported 
between veterinarians spending less or more than 50% of their working 
time treating sheep, with the median pain scores being 5 and 6 
respectively (P=0.1). 
The association between the numbers of analgesic classes (NSAIDs, 
alpha 2 agonists, local anaesthetics, dissociative anaesthetic agents) used 
for the different surgical procedures on the pain scoring was evaluated, 
but no statistically significant results were found (P>0.05).  
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The vast majority of veterinarians considered decreased ambulation, 
feeding and drinking as signs of pain in sheep, followed by immobility, 
hyperventilation, decreases interaction with other sheep and tachycardia 
(Figure 3.15). 
 
 
Figure 3.15. Indicators of pain in sheep according to Italian veterinarian 
responding to the questionnaire.  
 
 
 
 
In the respondents’ opinion, the main reason why analgesic drugs were 
not administered to sheep was the lack of licensed drugs, followed by 
costs, withholding times and regulations (Figure 3.16). 
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Figure 3.16. Reasons why analgesics drugs were not administered to 
sheep according to Italian veterinarians responding to the questionnaire.  
 
 
Section IV. Knowledge and continuing education on sheep analgesia 
The great majority of veterinarians (89.6%) considered their knowledge on 
sheep analgesia to be limited and were keen to improve it (96.5%) by 
attending congresses and seminars (79%), or with distance learning 
continuing professional education programmes (51.7%), or by reading 
scientific journals (51.7%) (Data not shown). 
 
3.4 Discussion 
 
To the author’s knowledge, this is the first questionnaire assessing the 
attitude of veterinarians towards recognition, assessment and treatment of 
pain in sheep. Similar published questionnaires have evaluated the same 
topic for other large animal species, in particular cattle, horses and pigs 
(Raekallio et al. 2003; Huxley & Whay 2006; Hewson et al. 2007a; 
Thomsen et al. 2010; Lorena et al. 2013). 
Only 31 veterinarians took part in the survey; the response rate is not 
known as the total number of veterinarians who received the e-mail was 
not known, but the number can be approximated to be 100-150. Moreover, 
the exact number of veterinarians dealing with sheep in Italy is unknown. 
Regulations 
Withholding time 
Costs 
Veterinary market license  
0 20 40 60 80 100 
R
ea
so
n
s 
w
h
y 
an
al
ge
se
si
cs
 a
re
 n
o
t 
ad
m
in
is
te
re
d
 t
o
 s
h
ee
p
 
Percentage of veterinarians 
 
 
 
 
84 
 
The current questionnaire is shorter than used in previous studies, this 
was done purposefully to encourage more responses, but this strategy 
was not successful and the number of responses obtained was very low. 
Publicity in specialised journals or direct mailing to practitioners could 
have increased the response rate, but it was not done for reasons of cost. 
It is difficult to tell if the respondents were representative of the sheep 
profession as a whole because of the voluntary nature of the questionnaire 
and the mailing database was not “audited” to reduce the risks of biased 
distribution, as previously commented by Huxley (Huxley & Whay 2006). 
Nevertheless considering the heterogeneity of gender and time since 
graduation, the dataset could be considered representative of sheep 
profession in Italy. This survey has considerably fewer respondents in 
comparison to other surveys but this was expected, as the questionnaire 
focused only on one species and sheep are not as common in Italy in 
comparison to other countries such as the United Kingdom or Australia. 
Similar questionnaires investigating analgesia in a single species, 
specifically in cattle, included only 137 (Becker et al. 2013) and 166 
(Laven et al. 2009) answers in contrast to 641 and 666 replies obtained in 
the United Kingdom (Huxley & Whay 2006) and in the States (Fajt et al. 
2011) respectively. Of the 31 replies, two had to be discarded as these 
two practitioners dealt only with goats and cattle but not with sheep; all the 
remaining 29 questionnaires were included in the study as all background 
data were present and more than 80% of questions were answered. More 
robust results might have been obtained with an increased number of 
replies; the sample size of this study is limited and this could have affected 
the outcome. 
Small ruminants breeding is performed mainly in the Southern Italy and 
Islands and this is mirrored by the results of this study which indicate that 
65.5% of veterinarians who responded to the survey work in this area 
where bigger flocks are located. Sheep practitioners who replied to the 
questionnaire were mainly males (69%), who graduated before 2005 
(55.2%) and achieved a post-graduation degree (86.3%). According to 
Italian statistics, the number of female graduating from veterinary school in 
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Italy has increased in the last few years (Mazzanti 2013), but according to 
this study it seems that sheep veterinarians are mainly male. 
None of the veterinarians usually administer opioids to sheep in the 
perioperative period. Experimental pain models using nociceptive 
stimulation have provided evidence for efficacy of intravenously 
administered opioids in sheep (Nolan et al. 1987c; Nolan et al. 1988; 
Waterman et al. 1990; Waterman et al. 1991a; Waterman et al. 1991b). 
Systemic and neuraxial administration of opioids has been reported in 
sheep undergoing experimental procedures and they have been proven to 
provide perioperative analgesia (Ahern et al. 2009; DeRossi et al. 2015), 
but they are not commonly used by practitioners (Hodgkinson 2007). This 
is because although opioids could be used in an extra-label manner 
according to the cascade principles, practitioners are put off by the long 
withdrawal times, labelling and records requirement, costs and limited 
knowledge of the pharmacokinetics and pharmacodynamics of these 
drugs.  
None of the respondents had ever used tramadol in sheep. Tramadol is a 
centrally acting opioid analgesic drug (Raffa et al. 1992) and is exempted 
from the safe custody requirements; it could potentially be a valuable 
option for use in sheep as it has been proven to be an useful adjunct in the 
management of perioperative pain in ruminants (Bigham et al. 2010; 
Habibian et al. 2011; Dehkordi et al. 2012). Moreover the author has 
investigated the pharmacokinetic and pharmacodynamics of tramadol in 
conscious sheep (Bortolami et al. 2015), but further studies are warranted 
before tramadol can be safely used in practice. 
The two most commonly used NSAIDs were flunixin meglumine and 
ketoprofen, followed by meloxicam and phenylbutazone. Similar results 
have been reported in other studies where flunixin meglumine, meloxicam 
and ketoprofen were the most frequently cited NSAIDs by British cattle 
practitioners (Huxley & Whay 2006), and flunixin meglumine, ketoprofen 
and phenylbutazone were the most frequently used NSAIDs in large 
animals in Brazil (Lorena et al. 2013). The great majority of practitioners 
(69%) administer NSAIDs in the perioperative period, especially after the 
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surgical procedure and this result is similar to that reported by Huxley in 
cattle (Huxley & Whay 2006). The use of NSAIDs has been proven to 
improve pain control following several commonly performed surgical 
procedures (Ting et al. 2003; Milligan et al. 2004) and so they should be 
routinely used as standard practice for these procedures (Huxley & Whay 
2006). Indeed, not only do NSAIDs have potent anti-inflammatory and 
analgesic properties, but they are also characterised by ease of parenteral 
administration and long duration of action (Valverde 2013). 
In the perioperative period provision of analgesia was provided by almost 
all practitioners by the use of local anaesthetics. Local anaesthetic 
techniques are indeed very common in small ruminants and cattle as the 
vast majority of the procedures can be carried out with standing sedation 
and local anaesthetics (Hodgkinson 2007; Valverde 2013). The 
importance of the use of neuraxial anaesthesia in sheep can be also 
deducted by the number of experimental studies evaluating it (Habibian et 
al. 2011; Moll et al. 2011; Dehkordi et al. 2012; DeRossi et al. 2012a; 
DeRossi et al. 2012b; Rostami & Vesal 2012; DeRossi et al. 2015). 
Advanced local anaesthetic techniques, such as epidural anaesthesia, 
were performed most commonly by practitioners who had been graduated 
for less than ten years, a result that was consistent with other studies 
(Lorena et al. 2013). 
Almost all practitioners, believed that procedures and medical conditions 
listed in the survey cause pain in sheep, with the condition perceived as 
causing the greatest pain being a fracture, followed by lameness and 
caesarean section and mastitis. 
In this study the overall median pain score assessed by women was 
higher than the one attributed by men and this was consistent with other 
studies’ findings (Huxley & Whay 2006; Laven et al. 2009; Lorena et al. 
2013). In the same studies higher pain scores were assigned by more 
recent graduates (Huxley & Whay 2006; Laven et al. 2009; Lorena et al. 
2013), but this was not found in this study. 
As in other studies, pain scores attributed by practitioners varied widely 
between them, and this confirms the subjective nature of pain assessment 
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in animals (Huxley & Whay 2006). Unlike people, animals are unable to 
verbalise their feelings, so pain assessment is based primarily on 
behavioural and physiological evaluations (Hardie 2000; Rutherford 2002). 
According to the practitioners’ opinion collated in this survey, sheep 
manifest their pain by decreasing movement, food and water intake and 
physiological changes such as tachycardia and hyperventilation can be 
observed. These opinions are consistent with indicators of pain previously 
reported in cattle (Stafford 2014). 
Not only pain recognition and assessment is difficult in sheep but also its 
treatment. 
Indeed, to the practitioners’ opinion the main reason why analgesics drugs 
were not administered to sheep was the lack of licensed drugs, followed 
by costs, withholding times and regulations. Registration for use in food 
producing animals is the most important factor to be considered, and this 
explains why practitioners do not administer opioids. In the author’s 
opinion the approval of drugs for treatment of painful states in food 
producing animal may increase the use of analgesics by veterinarians. 
Nevertheless costs were also considered an important aspect to take into 
account; which is consistent with other studies (Huxley & Whay 2006; 
Hewson et al. 2007b). The practitioners’ use of analgesics is influenced by 
the farmers’ concerns about the cost effectiveness of drugs compared to 
the value of the livestock (Huxley & Whay 2006; Gottardo et al. 2011), and 
the industry’s narrow profit margins. Spending money on analgesia can be 
cost effective, as the provision of analgesia for dehorning and castration 
has been proven to improve growth rates in cattle (Faulkner & Weary 
2000; Stafford & Mellor 2005b; Stafford & Mellor 2005a; Vickers et al. 
2005). Finally, analgesia improves not only animals’ wellbeing and 
productivity but also handling calm and pain-free animals will increase 
practitioner’s safety. In order to improve farmers and veterinarians’ 
knowledge regarding the benefits of analgesia, continuing education 
should be provided. The vast majority of the practitioners were interested 
in improving their knowledge regarding pain assessment and treatment in 
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sheep; this willingness is therefore the first step towards a better 
management of sheep analgesia. 
 
3.5 Conclusions 
 
Welfare of animals has its basis in pain treatment. Surveys investigating 
practitioners’ attitudes on analgesia are important to provide 
understanding of their practices and help to target professional 
development programs in order to improve animal care.  
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Chapter 4 
 
PHARMACOKINETICS AND 
ANTINOCICEPTIVE EFFECTS OF TRAMADOL 
AND ITS METABOLITE M1 FOLLOWING 
INTRAVENOUS ADMINISTRATION IN SHEEP 
__________________________________________ 
 
4.1 Introduction 
 
Sheep are widely used as an experimental model for various surgical 
procedures (Coulter et al. 2009). In spite of this, there is a paucity of data 
regarding the pharmacokinetics and efficacy of analgesic drugs in this 
species. There is a clear need to identify analgesic drugs, dose and dose 
interval for use in sheep during invasive experimental procedures. 
Tramadol is an analgesic drug widely used in people and in small animals; 
it possesses a weak agonist action against the Mu (µ) opioid receptor and 
inhibits the reuptake of norepinephrine and serotonin (Raffa et al. 1992). 
The active metabolite, O-desmethyltramadol (M1) has an affinity for the μ 
opioid receptor that is 300 times greater than that of tramadol (Grond & 
Sablotzki 2004). No studies investigating the analgesic efficacy of 
tramadol in sheep have been performed so far. However, the 
pharmacokinetics and biotransformation of tramadol have been studied in 
several animal species including the dog, cat, goat, llama, alpaca, horse 
and donkey (KuKanich & Papich 2004; Giorgi et al. 2007; de Sousa et al. 
2008; Pypendop & Ilkiw 2008; Giorgi et al. 2009b; Cox et al. 2011; Stewart 
et al. 2011; Edmondson et al. 2012), highlighting species-specific 
differences in the kinetic profiles of both the parent drug and its 
metabolites. 
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Although the effectiveness of tramadol is still unclear in veterinary 
medicine (Giorgi 2012), there are studies confirming the analgesic efficacy 
of tramadol for the management of peri-operative pain in other ruminants 
(Habibian et al. 2011; Dehkordi et al. 2012). 
To evaluate the analgesic or antihyperalgesic efficacy of opioid drugs, 
nociceptive threshold testing, or analgesiometry, can be used. It consists 
of the application of a measurable stimulus, usually mechanical, thermal or 
electrical, in order to obtain a clear behavioural response and record the 
threshold at which the animal responded. If the tested drug exerts 
analgesic or antihyperalgesic effect, the threshold will either increase or 
remain unchanged (for example, when thresholds are measured following 
induction of inflammation). Mechanical nociceptive threshold (MNT) testing 
devices have already been tested and validated in sheep (Nolan et al. 
1987a; Musk et al. 2014). 
The aim of this study was to investigate the pharmacokinetic profile and 
antinociceptive efficacy of two different doses of tramadol administered 
intravenously to sheep. 
 
4.2 Materials and methods 
 
Animals and treatments 
Six female adult Brogna sheep, body mass between 38 and 55 kg, were 
enrolled in this study, which was performed with approval from the ethical 
committee for animal experimentation of the University of Padua (CEASA 
80/2012, 30 April 2013) and according to EC Council Directive 86/609EEC 
(Council of the European Communities, 1986). All animals were 
considered healthy based on clinical examination and haematological 
analyses. Sheep were kept indoors in a group pen (400 cm x 400 cm) in 
the Large Animal Facility at the University of Padua and fed a commercial 
pellet and hay diet. On the day of the experiment, a group of three sheep 
were moved into individual stalls where animals remained in visual contact 
with each other. The dimensions of each pen were: length 160 cm, width 
66 cm and height 110 cm. Pens were bedded with straw. Sheep were 
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acclimatized to the stalls, handlers, mechanical nociceptive threshold 
(MNT) probe and MNT testing procedure prior to commencing the study. 
Sheep were deprived of food for 8 h prior to the start of the experiment 
while water was available ad libitum. Hay and water were available ad 
libitum 2 h after treatment administration. Two 14 G catheters (Delta Ven, 
DeltaMed) were placed in the right and left jugular veins, to allow both 
treatment administration and collection of blood for the pharmacokinetic 
analysis. All six sheep received the following three treatments 
intravenously over 2 min via the left jugular catheter: Tramadol 4 mg/kg 
(Group T4) (Tramadolo Hexal Ag, Hexal), Tramadol 6 mg/kg (Group T6), 
and 5 mL of Sodium Chloride 0.9% (Group SAL). Drugs were administered 
in a randomly allocated, crossover design with a 2-week wash out period 
between treatments. Investigators were blinded to treatment allocation. 
 
Blood sampling and clinical evaluation 
Five mL of blood was collected from the right jugular vein before drug (or 
saline) administration, 5, 10, 15, 30, 45 min and 1, 1.5, 2, 4, 6, 8, 12 and 
24 h after administration. Whole blood was placed in lithium-heparinized 
tubes and centrifuged at 2000 g for 5 min. The harvested plasma was 
frozen at -80 °C until pharmacokinetic analysis was performed. 
Immediately before and 15, 30 min and 1, 1.5, 2, 4, 6, 8, 10 and 12 h after 
drug administration, heart and respiratory rates were determined by 
thoracic auscultation and observation of thoracic excursions respectively. 
Rectal temperature and reticulo-ruminal motility, assessed by auscultation 
of the rumen (number of cycles in 5 min), were monitored starting from 30 
min after drug administration. Sedation was quantified using a 0-100 mm 
visual analogue scale (VAS) scale where 0 mm was considered no 
sedation and 100 was considered very deep sedation / unconsciousness. 
Any adverse events attributed to the drug treatment were noted 
throughout the course of the study. 
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MNT Testing  
MNT was measured by a single investigator using the ProdPro (Topcat 
Metrology Ltd), as described elsewhere (Dixon et al. 2010). Briefly, this is 
a mechanical testing device comprising a cuff with a 2 mm hemispheric 
blunt pin fixed on a rolling diaphragm actuator and applied perpendicular 
to the skin of the test area, in this case the dorsal aspect of the right 
metacarpus approximately 4 cm below the carpus. The pin was pushed 
against the skin with a force which was applied manually by a syringe, 
connected to non-distensible tubing via a digital meter which displayed the 
force exerted, until a clear withdrawal response (leg lift, head turn, weight 
bearing on the contra-lateral limb) was evoked. The force at which the 
sheep responded with a clear withdrawal response was recorded as the 
MNT. A dummy actuator, identical to the test actuator apart from the fact 
that it did not contain the pin was secured to the contra-lateral limb. A cut 
off point was set at 25 N in order to prevent tissue trauma should a clear 
withdrawal response not be elicited. Figure 4.1 shows the MNT device 
used in this study. 
 
The MNT was measured prior to blood collection at time point 0, 
immediately before drug administration (baseline), 15, 30, 45 min and 1, 
1.5, 2, 4, 6, 8, 10 and 12 h after drug administration. In order to calculate 
the MNT, 3 measurements were performed at each time point with an 
interval of at least 2 min between each measurement and the mean was 
used for statistical analysis; five tests were performed and averaged to 
obtain the baseline MNT. 
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Figure 4.4. MNT device uses in this study. 
 
 
 
Tramadol and M1 determination in blood  
Based on a previously published High Performance Liquid 
Chromatography (HPLC) technique (Giorgi et al. 2009a), the analytical 
method was briefly re-validated in sheep plasma. The HPLC was a Liquid 
Chromatographic system (Jasco) consisting of high-pressure mixer pump 
(model PU 980 Plus), spectrofluorometric detector (model 2020 Plus) and 
a loop of 20 μL. Data were processed by Borwin software (Jasco). 
Chromatographic separation assay was performed by a Luna C18 ODS2 
analytical column (150 x 4.6 mm inner diameter, 3 μm particle size, 
Phenomenex) maintained at 25 °C. The mobile phase consisted of 
acetonitrile:buffer (20 mM sodium dihydrogen phosphate, 30 mM Sodium 
Dodecyl Sulfate, and 15 mM triethylamine, adjusted to pH 3.9 with 
phosphoric acid) (40:60 V/V) at a flow rate of 0.8 mL/min. Excitation and 
emission wavelengths were 275 and 300 nm, respectively. The analytical 
method used in this study was able to differentiate the three main 
metabolites (M1, M2 and M5). However, the M2 and M5 plasma 
concentrations are not presented here as they are inactive metabolites 
and hence of negligible importance for the study. 
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Pharmacokinetic analysis 
The pharmacokinetic parameters were calculated for each subject from 
tramadol and M1 plasma concentrations vs. time curves using WinNonLin 
v 5.3 (Pharsight Corp). The comparison between competing models (one- 
vs. two-compartment) was made using the Akaike test. The best fit was 
described by a two-compartment open and a non-compartmental model, 
for tramadol and M1, respectively. The area under the concentration vs. 
time curve (AUC0-) was calculated using the linear trapezoidal rule 
(Gibaldi and Perrier, 1982). 
 
Statistical analysis 
Sample size calculations were performed before commencing the study. 
For a two way repeated measures ANOVA with a difference between ∆ 
MNT means (∆ MNT= MNT value at a specific time point minus baseline 
MNT value) of 3.5 N, standard deviation (SD) = 2, β = 0.8 and α = 0.05, a 
minimum of 6 animals per group were required. Residuals of repeated 
measures for ∆ MNT, heart rate, respiratory rate, body temperature were 
analyzed for normality using the Shapiro-Wilk test. 
Normally distributed data were analysed by a repeated mixed linear model 
with the fixed effects of treatment, time and their interaction and animal as 
a random effect (Littell et al., 1998). Reticulo-ruminal motility was analysed 
by a non-parametric approach (Kruskal-Wallis) to test the effect of 
treatment at the different time points. Data analyses were performed using 
SAS statistical software (version 9.3, SAS Institute). P values < 0.05 were 
deemed significant. 
 
4.3 Results 
 
Pharmacokinetics 
The tramadol and M1 concentrations vs. time after IV administration of 4 
and 6 mg/kg of tramadol are reported in Fig. 4.2 and Fig 4.3 respectively. 
The limits of detection (LOD) were 1 ng/mL and 3 ng/mL and the limits of 
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quantification (LOQ) were 5 ng/mL and 10 ng/mL for T and M1, 
respectively. The values of precision for both analytes were always lower 
or equal to 9.8 (CV%), while accuracy was less than 7.3%. 
Serum concentrations after IV administration of 4 mg/kg and 6 mg/kg of 
tramadol in sheep are shown in Table 4.1, while serum concentrations of 
M1 after IV administration of 4 mg/kg and 6 mg/kg of tramadol in sheep 
can be visualised in Table 4.2. At the first time point (5 min) the plasma 
concentrations of tramadol were 1.29 ± 0.17 µg/mL and 1.56 ± 0.10 µg/mL 
following treatment with 4 mg/kg and 6 mg/kg tramadol respectively. At the 
subsequent time points, tramadol plasma concentrations decreased 
rapidly for both treatments and were detectable in all animals only up to 4 
h post-administration. At 6 h, tramadol was detectable in 5 out of 6 sheep 
after treatment with 6 mg/kg and following administration of 4 mg/kg, was 
detectable at this time point in 4 out of 6 animals. The active metabolite 
(M1) was detectable in the plasma 5 min after tramadol administration, 
with a concentration equal to 0.13 ± 0.02 and 0.14 ± 0.03 µg/mL after 
administration of 4 and 6 mg/kg of tramadol, respectively. Similar plasma 
concentrations were maintained up to 45 min and then plasma 
concentrations decreased over the next 4 h. At time points later than 4 h, 
plasma concentrations of M1 were < LOQ.  
The most important pharmacokinetic parameters of tramadol and M1 are 
reported in Tables 3 and 4, respectively. 
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Figure 4.2. Average tramadol (solid line, tringle) (-▲-) and M1 (dotted line, 
square) (-■-) concentrations vs. time after IV administration of tramadol 4 
mg/kg (Group T4) (n=6). Bars represent the standard deviation. 
 
 
 
 
 
Figure 4.3. Average tramadol (solid line, tringle) (-▲-) and M1 (dotted line, 
square) (-■-) concentrations vs. time after IV administration of tramadol 6 
mg/kg (Group T6) (n=6). Bars represent the standard deviation. 
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Table 4.1 - Serum concentrations (mean ± standard deviation) of Tramadol 
after IV administration of 4 mg/kg (Group T4) and 6 mg/kg ( Group T6) of 
tramadol in sheep (n=6). 
 
TIME POST-
ADMINISTRATION 
(min) 
GROUP T4:                    
Tramadol 
Concentration 
(µg/mL) mean (± S.D.) 
GROUP T6:                          
Tramadol 
Concentration 
(µg/mL) mean (± S.D.) 
5 1.295 ± 0.167 1.564 ± 0.103 
15 0.702 ± 0.067 0.978 ± 0.186 
30 0.426 ± 0.065 0.576 ± 0.144 
45 0.280 ± 0.045 0.386 ± 0.096 
60 0.187 ± 0.028 0.286 ± 0.107 
90 0.106 ± 0.034 0.138 ± 0.036 
120 0.057 ± 0.016 0.085 ± 0.021 
240 0.018 ± 0.012 0.015 ± 0.007 
 
 
Table 4.2 - Serum concentrations (mean ± standard deviation) of M1 after 
IV administration of 4 mg/kg (Group T4) and 6 mg/kg (Group T6) in sheep 
(n=6). 
TIME POST-
ADMINISTRATION 
(min) 
GROUP T4:                    
Tramadol 
Concentration 
(µg/mL) mean (± 
S.D.) 
GROUP T6:                          
Tramadol 
Concentration 
(µg/mL) mean (± 
S.D.) 
5 0.130 ± 0.022 0.143 ± 0.028 
15 0.113 ± 0.017 0.140 ± 0.024 
30 0.113 ± 0.036 0.139 ± 0.028 
45 0.116 ± 0.028 0.140 ± 0.042 
60 0.108 ± 0.020 0.129 ± 0.035 
90 0.086 ± 0.025 0.108 ± 0.039 
120 0.067 ± 0.020 0.092 ± 0.035 
240 0.019 ± 0.007 0.027 ± 0.012 
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Table 4.3. Main average pharmacokinetic parameters of tramadol following 
tramadol IV administration at 4 mg/kg (Group T4) and 6 mg/kg in sheep 
(Group T6) (n = 6). 
 GROUP T4 GROUP T6 
PARAMETER Unit Mean SD Mean SD 
k10   1/h 6.895 7.350 2.210 0.381 
k12  1/h 7.652 10.137 1.658 1.188 
k21   1/h 3.102 1.243 3.062 1.269 
t 1/2α h 0.091 0.078 0.161 0.118 
t 1/2β h 0.671 0.419 0.573 0.116 
V1 L/kg 1.572 1.151 2.870 0.120 
CL1 L/kg/h 4.862 1.191 6.315 0.949 
V2  L/kg 1.694 0.890 1.415 0.796 
CL2  L/kg/h 4.466 1.473 4.732 3.509 
AUC 0-∞ μg/mL*h 0.870 0.236 0.968 0.145 
AUMC  μg/mL*h2 0.539 0.245 0.671 0.215 
MRT  h 0.651 0.337 0.686 0.137 
Vss L/kg 3.266 1.919 4.285 0.745 
 
AUC 0-∞, area under serum concentration-time curve from time zero to infinity; 
 AUMC, area under moment curve; 
CL1, clearance of central compartment; 
CL2, clearance of peripheral compartment; 
k10, the rate at which the drug leaves the system from the central compartment (the 
elimination rate); 
k12, the rate at which the drug passes from central to peripheral compartment; 
k21, the rate at which the drug passes from peripheral to central compartment; 
MRT, mean residence time; 
t½ α, distribution half-time; 
t½ β, elimination half-time; 
V1, volume of distribution in central compartment; 
V2, volume of distribution in peripheral compartment; 
Vss, volume of distribution at steady state; 
SD, standard deviation. 
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Table 4.4. Average pharmacokinetic parameters of M1 following tramadol 
IV administration at 4 mg/kg (Group T4) and 6 mg/kg (Group T6)in sheep 
(n = 6). 
 GROUP T4 GROUP T6 
PARAMETER Unit Mean SD Mean SD 
z 1/h 0.606 0.084 0.580 0.142 
t ½ z h 1.163 0.163 1.266 0.350 
Tmax obs h 0.373 0.334 0.402 0.267 
Cmax obs μg/mL 0.141 0.020 0.159 0.037 
AUC 0-∞ obs μg/mL*h 0.317 0.077 0.414 0.128 
MRT 0-∞ obs h 1.810 0.244 1.974 0.388 
 
AUC 0-∞ obs, area under serum concentration-time curve from time zero to infinity;  
C , Maximum concentration observed;  
MRT 0-∞ obs, mean residence time from time zero to infinity;  
Tmax obs, Time of maximum concentration observed;  
t½λz, terminal half-time. 
SD, standard deviation. 
 
Clinical evaluations 
Mild self-limiting adverse events were noticed in all animals in Group T6 
and in 4 animals in Group T4. These included tremors, muscle 
fasciculation, ataxia, agitation, urination and defecation that started 15-30 
s after the beginning of drug administration and lasted for a maximum of 
10 min. The severity of adverse events was greater in Group T6 but in all 
cases they spontaneously resolved. No adverse events were recorded in 
Group SAL.  
Heart rate, respiratory rate, temperature and reticulo-ruminal motility were 
not statistically different within each group in comparison to baseline 
values nor between groups at any time points (P> 0.05). 
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Tables 4.5, 4.6, 4.7, 4.8 show the results relative to the physiological 
parameters. 
No sedation was observed during the experiment in any group (VAS = 0 
mm) (data not shown). 
 
Table 4.5. Mean (± SD) heart rate after administration of Tramadol 4 mg/kg 
(Group T4), Tramadol 6 mg/kg (Group T6) and Sodium Chloride 0.9% 
(SAL) at different time points in sheep (n=6). Values are expressed in 
beats per minute. 
TIME 
POINTS 
SAL GROUP T4 GROUP T6 
Basal 
values 
78 (±8,29) 74 (±2,19) 78,33 (±12,027) 
0,25 h 73 (±8,74) 74 (±8,67) 89,33 (±25,63) 
0,5 h 72,66 (±6,40) 72,66 (±9,26) 82,33 (±20,87) 
0,75 h 70 (±7,04) 77,66 (±7,20) 73,33 (±11,77) 
1 h 72,33 (±6,74) 72,66 (±11,14) 75,33 (±12,75) 
1,5 h 70 (±6,57) 77,66 (±8,16) 77,33 (±13,30) 
2 h 72 (±9,38) 74,66 (±8,64) 77,33 (±13,06) 
4 h 76 (±6,69) 76 (±8,76) 78 (±11,52) 
6 h 72 (±10,43) 76 (±9,46) 77,33 (±10,93) 
8 h 73,66 (±8,80) 73,33 (±11,77) 70 (±12,83) 
10 h 70,66 (±8,26) 71,66 (±8,98) 66,66 (±18,53) 
12 h 69 (±8,17) 69,33 (±10,32) 74,66 (±6,53) 
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Table 4.6. Mean (± SD) respiratory rate (beat per minutes) after 
administration of Tramadol 4 mg/kg (T4), Tramadol 6 mg/kg (T6) and 
Sodium Chloride 0.9% (SAL) at different time points in sheep (n=6).  
TIME POINTS SAL GROUP T4 GROUP T6 
Basal values 71 (±15,78) 67,33 (±29,97) 75,33 (±32,04) 
0,25 h 86,66 (±32,75) 78 (±14,47) 73,33 (±21,11) 
0,5 h 70,33 (±37,53) 79,33 (±22,96) 71,33 (±28,33) 
0,75 h 66 (±20,35) 76,66 (±31,12) 64,33 (±15,92) 
1 h 60,66 (±13,24) 85,33 (±17,82) 73,33 (±25,12) 
1,5 h 76,66 (±26,94) 76,66 (±16,13) 86,66 (±32,26) 
2 h 72,66 (±22,96) 66,66 (±22,54) 80 (±32,32) 
4 h 74 (±16,92) 68 (±22,05) 60,66 (±13,24) 
6 h 61,66 (±13,17) 64,33 (±16,89) 65,33 (±15,31) 
8 h 58,66 (±17,09) 62,33 (±23,40) 63,33 (±35,63) 
10 h 60,33 (±14,66) 57,33 (±15,31) 57,66 (±15,92) 
12 h 56 (±19,59) 58,33 (±14,01) 52,66 (±17,42) 
 
Table 4.7. Mean (± SD) rectal temperature, in degree Celsius (°C), after 
administration of Tramadol 4 mg/kg (T4), Tramadol 6 mg/kg (T6) and 
Sodium Chloride 0.9% (SAL) at different time points in sheep (n=6).  
TIME 
POINTS 
SAL GROUP T4 GROUP T6 
Basal values 39,98 (±0,49) 40,03 (±0,55) 39,91 (±0,48) 
0,25 h 39,85 (±0,52) 40,1 (±0,56) 39,8 (±0,61) 
0,5 h 39,7 (±0,44) 40,11 (±0,52) 39,96 (±0,67) 
0,75 h 39,68 (±0,48) 40,08 (±0,49) 39,9 (±0,55) 
1 h 39,53 (±0,45) 39,98 (±0,59) 39,73 (±0,56) 
1,5 h 39,51 (±0,47) 39,7 (±0,38) 39,58 (±0,58) 
2 h 39,6 (±0,33) 39,71 (±0,45) 39,53 (±0,58) 
4 h 39,48 (±0,51) 39,56 (±0,39) 39,4 (±0,55) 
6 h 39,56 (±0,51) 39,5 (±0,44) 39,36 (±0,50) 
8 h 39,31 (±0,49) 39,45 (±0,40) 39,33 (±0,50) 
10 h 39,33 (±0,33) 39,41 (±0,34) 39,26 (±0,34) 
12 h 39,51 (±0,29) 39,11 (±0,38) 39,38 (±0,37) 
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Table 4.8. Mean (± SD) ruminal cycles (assessed by auscultation of the 
rumen for 5 minutes) after administration of Tramadol 4 mg/kg (Group T4), 
Tramadol 6 mg/kg (Group T6) and Sodium Chloride 0.9% (SAL) at 
different time points in sheep (n=6). Values are expressed number of 
cycles in 5 min. 
 
TIME POINTS SAL GROUP T4 GROUP T6 
Basal values 3,5 (±0,54) 3,33 (±1,21) 3,66 (±1,36) 
0,5 h 3,66 (±0,81) 3,5 (±0,83) 3,16 (±0,98) 
1 h 3,66 (±0,81) 4 (±0,63) 4 (±1,26) 
1,5 h 3,83 (±1,47) 3,83 (±0,98) 3,66 (±1,36) 
2 h 3,5 (±1,3) 4 (±0,63) 3,66 (±1,03) 
4 h 4 (±0,89) 4,66 (±1,36) 4,5 (±0,83) 
6 h 4,5 (±1,37) 3,83 (±0,98) 3,66 (±0,81) 
8 h 4,5 (±0,83) 4,16 (±1,32) 3,83 (±0,98) 
10 h 4,5 (±0,83) 4,66 (±0,81) 4 (±1,09) 
12 h 4,33 (±1,03) 4 (±0,89) 4 (±1,26) 
 
MNT Testing  
Animals reacted to the MNT stimulation with a leg lift or head turn. The cut 
off value of 25 N was never reached during the study and no signs of 
tissue trauma or lameness were observed in sheep. There were no 
significant differences between groups in MNT baseline values; the overall 
baseline MNT was 8 ± 1.9 N. Table 4.9 shows results relative to MNT test. 
There were no differences in ∆ MNT between groups at any time point (P 
> 0.05). Independently from treatment, at 15 and 30 min post-
administration the ∆ MNT values were significantly higher than those 
observed from the 360 min time point onwards (P < 0.001). 
∆ MNT values are shown in Fig. 4.4. Within-group comparisons showed 
that there were no statistically significant differences between the basal 
MNT and the MNT at any different time point (P > 0.05). 
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Table 4.9. Median (± SD) MNT data after administration of Tramadol 4 
mg/kg (Group T4), Tramadol 6 mg/kg (Group T6) and Sodium Chloride 
0.9% (SAL) at different time points in sheep (n=6). Values are expressed 
in Newton (N). 
TIME POINTS SAL GROUP T4 GROUP T6 
Basal values 8,88 (± 2,45) 7,37 (±1,01) 7,94 (± 1,06) 
0,25 h 7,96 (± 3,32) 8,63 (± 1,59) 8,92 (± 2,39) 
0,5 h 8,22 (± 2,52) 7,76 (± 1,55) 8,36 (± 1,67) 
0,75 h 7,64 (± 2,99) 7,57 (± 1,24) 7,43 (± 3,22) 
1 h 7,57 (± 1,66) 6,85 (± 1,50) 7,14 (± 1,82) 
1,5 h 6,85 (± 2,31) 6,52 (± 0,84) 6,26 (± 1,98) 
2 h 6,94 (± 2,50) 6,56 (± 1,44) 6,41 (± 1,09) 
4 h 7,31 (± 1,67) 6,22 (± 0,85) 6,56 (± 1,25) 
6 h 6,93 (± 1,29) 5,90 (± 0,99) 5,95 (± 1,39) 
8 h 5,80 (± 1,04) 6,44 (± 0,71) 5,56 (± 1,14) 
10 h 6,08 (± 1,71) 5,75 (± 0,75) 5,64 (± 1,25) 
12 h 6,73 (± 1,71) 5,72 (± 0,46) 5,59 (± 1,76) 
 
Figure 4.4. ∆ MNT values at the different time points in the three groups of 
sheep (n = 6). Saline = grey; T4 = light grey; T6= dark grey. Bars represent 
the standard deviation 
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4.4 Discussion 
 
Sheep are widely used for invasive biomedical research but there are 
limited data surrounding analgesic drug administration in this species. Few 
analgesic drugs have Market Authorisation for use in ruminants but those 
that are available include non-steroidal anti-inflammatory drugs (NSAIDs), 
α2-agonists and local anaesthetic agents. In people tramadol provides 
good analgesia with only mild effects on cardio-respiratory function and 
intestinal motility (Raffa et al., 1992) and is not currently subject to 
Controlled Drug legislation in Europe. The tramadol doses chosen in the 
present study were extrapolated from previous studies in other ruminant 
species (de Sousa et al. 2008; Cox et al. 2011; Edmondson et al. 2012). A 
pharmacokinetic study in goats evaluated 2 mg/kg tramadol (de Sousa et 
al. 2008) and the resulting data suggested that 4 mg/kg would be an 
appropriate dose to achieve plasma concentrations that might be 
consistent with analgesia, although antinociceptive / analgesic efficacy 
was not measured concurrently in that study. 
The plasma concentration vs. time profiles (Fig. 1) of tramadol and M1 
were similar after the two doses. Blood concentrations of tramadol in 
sheep declined quickly as evidenced by the very short half-life and high 
clearance value after administration of 4 and 6 mg/kg. The elimination half-
life values in this study were lower than those observed in other species 
such as goats (0.94 h) (de Sousa et al. 2008), alpacas (0.78-0.85 h) 
(Giorgi et al. 2010; Edmondson et al. 2012), and llamas (2.12 h) (Cox et 
al. 2011). In the present study, the formation of the active metabolite M1 
was observed in all sheep. This is in agreement with an earlier study in 
goats (de Sousa et al. 2008), while in alpacas (Giorgi et al. 2010) M1 was 
detected in only 1 out of 8 treated animals. In this study, the ratio of AUCs 
for M1/T was equal to 0.36 and 0.43 after IV administration of 4 mg/kg and 
6 mg/kg of tramadol, respectively. These similar values suggest that the 
metabolic system of the sheep is not saturated at doses up to 6 mg/kg. 
This ratio value is similar to that found in dogs (0.31) (KuKanich & Papich 
2004), and in goats (0.28) (de Sousa et al. 2008), and lower than that 
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observed in llamas (0.94) (Cox et al. 2011) and in cats (AUCs ratio M1/T 
>1) (Pypendop & Ilkiw 2008). These comparisons indicate that M1 has a 
more prominent role in the pharmacokinetics of tramadol in cats and 
llamas compared to sheep. In people, the minimum effective 
concentrations reported for tramadol and M1 are 0.3 ± 0.2 µg/mL 
(Lehmann et al. 1990) and 0.08 ± 0.03 µg/mL (Grond et al. 1999) 
respectively. In this study, tramadol in plasma was above the human 
therapeutic concentration up to 45 min after drug administration while the 
M1 plasma concentrations considered effective in people were maintained 
in sheep plasma up to 2 h post treatment. Surprisingly, in the present 
study a mechanical antinociceptive effect of tramadol was not detected in 
the first h after drug administration, when plasma levels of tramadol and 
M1 were similar to analgesic concentrations reported in people.  
Quantitative sensory testing methods have been used in conscious painful 
and non-painful/healthy sheep in order to assess the efficacy of analgesic 
drugs, including opioids (Nolan et al. 1988; Waterman et al. 1991a; Kyles 
et al. 1993b; Musk et al. 2014), NSAIDs (Welsh & Nolan 1994; Welsh & 
Nolan 1995b; Lizarraga & Chambers 2006) and α2-agonists (Grant et al. 
2001; Grant & Upton 2004; Musk et al. 2014). In this study no statistically 
significant difference in MNT was found between groups. These results 
are consistent with other studies performed in conscious healthy sheep. 
Buprenorphine (6 µg/kg IV) was found to exert antinociceptive activity in a 
thermal nociceptive threshold test but not in the mechanical one (Nolan et 
al. 1987c); butorphanol (0.1-0.4 mg/kg IV) did not cause any significant 
elevation in mechanical pressure threshold (Waterman et al. 1991a); 
pethidine (5 mg/kg IV) increased thermal threshold for 30 min but pressure 
threshold only for a few minutes (Nolan et al. 1988) and pethidine and 
fentanyl caused a brief increase in mechanical threshold values (Nolan et 
al. 1987a). Clearly a more complete evaluation of analgesic effects of a 
drug should be performed using more than one type of stimulus (Tyers 
1980). Thermal nociceptive threshold testing was not performed in this 
study, not only because of the unavailability of the equipment and for 
economical reasons but also because it has been reported to cause skin 
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damage in sheep (Musk et al. 2014), most likely because of the stoic 
attitude of this pray species. Moreover, when tramadol was tested in 
conscious horses at the dose of 2 mg/kg, no changes were detected with 
a thermal nociceptive threshold model (Dhanjal et al. 2009). 
The lack of efficacy of tramadol observed in the present study may be due 
to several reasons. It might be that the achieved plasma concentrations of 
tramadol were not sufficient to promote antinociception in sheep and that 
higher plasma concentrations would be required. Genetic variabilities were 
shown to affect tramadol metabolism in people (Pedersen et al. 2006) and 
this may apply to sheep as well. A variation in the analgesic effect of 
xylazine in different breeds of sheep has been reported (Ley et al. 1990). 
Another reason may be that sheep tend to mask signs of nociception, 
nevertheless in the current study very clear behavioral end points to the 
MNT test were produced and sheep did not reach the cut-out values. In 
this study xylazine, which has been shown to cause an increase in the 
mechanical nociceptive threshold in sheep (Nolan et al. 1987b), was not 
used as a positive control: it would have increased the mechanical 
nociceptive threshold but it would be difficult to differentiate between 
sedation and analgesia. 
It should be pointed out that a major limitation of nociceptive threshold 
testing is that it does not provide the same stimulus as clinical pain, as 
commented by Love and colleagues (Love et al. 2011). It may be possible 
that the analgesic effects of tramadol would be detected in clinical pain 
states. 
The MNT decreased with time in all groups, which might be explained by a 
sensitization to the MNT test. This finding is consistent with previous 
reports of MNT measurement in sheep (Stubsjoen et al. 2010) and could 
be another reason why no analgesic effect of tramadol was detected in 
this study. On the other hand, in another study the mechanical nociceptive 
threshold did not vary over 14 days in conscious healthy sheep (Abu-
Serriah et al. 2007). In this study, in order to prevent bias, the same 
observer performed the MNT test and animals were acclimatized to 
research personnel, equipment, procedures and stables.  
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After tramadol administration, adverse events, including muscle 
fasciculation, tremors, agitation and ataxia, were noticed in the majority of 
animals, but these were short lasting and self-limiting and not deemed to 
be clinically problematic. This is consistent with findings described in 
alpacas (Giorgi et al. 2010; Edmondson et al. 2012), llamas (Cox et al. 
2011), and horses (Giorgi et al. 2007; Stewart et al. 2011). Although drugs 
were injected over 2 min, adverse events were still observed. In people, 
dose and speed of infusion of tramadol affect the incidence of adverse 
events (Grond & Sablotzki 2004). Therefore in the clinical setting in sheep, 
a slow infusion rate, over 10 min, may produce less adverse effects. 
Compared to saline, tramadol administration did not affect physiological 
parameters including heart rate, respiratory rate and rectal temperature. 
Respiratory rates, including the basal ones, were high but this was due to 
the fact that respiratory rate was the last parameter to be evaluated, after 
blood collection, MNT test and other physiological parameters record. 
Other Authors have also observed an absence of change in these 
parameters after epidural administration of tramadol in goats and cows 
(Bigham et al. 2010; Dehkordi et al. 2012). In contrast, a study conducted 
in lambs has shown changes in rectal temperature and heart and 
respiratory rate (Habibian et al. 2011). These incongruities might be the 
result of having adult versus juvenile subjects and differences in route of 
administration. In this study tramadol was shown not to affect gut motility; 
this might be due to the low affinity of tramadol for the µ-opioid receptor 
and thus tramadol may be advantageous in this species. Tramadol 
administered to horses at the dose of 2 mg/kg IV was shown not to alter 
the faecal output although a short lived (40 min) decrease in borborygmus 
score was reported (Dhanjal et al. 2009). Further studies could be 
performed to assess the effect of tramadol on gastrointestinal motility by 
quantification of faecal output (Love et al. 2012) or using radiopaque 
spheres (Sano et al. 2011). 
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4.5 Conclusions 
 
Intravenous administration of tramadol at 4 and 6 mg/kg in sheep was 
associated with rapid metabolism and a transient presence of M1 in 
plasma; antinociceptive effects were not detected with an MNT model. 
This study provided the pharmacokinetic data of tramadol in sheep; further 
studies are warranted to assess its clinical efficacy in animals experiencing 
pain. 
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Chapter 5 
 
GENERAL CONCLUSIONS 
______________________ 
 
Sheep are widely used in experimental settings and in breeding systems, 
nevertheless pain treatment in this species seems to be overlooked. 
In particular, in the vast majority of research papers, anaesthetic and 
analgesic treatment is not properly and accurately reported, while in the 
clinical setting administration of analgesic drugs is limited due to financial 
concerns and lack of licensed drugs. 
Tramadol is a drug exerting opioid and non-opioid analgesic activity, which 
exhibited low incidence of adverse effects in people and is not a 
scheduled drug. For this reason it seemed to have potential for its use in 
sheep.  
The study carried out showed that tramadol was rapidly metabolised in 
sheep and that O-desmethyltramadol’s plasmatic concentrations 
decreased quickly. A mechanical antinociceptive effect of tramadol was 
not detected in sheep. A major limitation of nociceptive threshold testing is 
that it does not provide the same stimulus as clinical pain and more than 
one nociceptive stimulus should be used. It may be possible that the 
analgesic effect of tramadol would be detected in clinical pain states. 
Further studies would include the evaluation of tramadol in sheep 
undergoing a surgical procedure or suffering from a painful condition. 
These studies showed that there is a lot of room for improvement in pain 
assessment and treatment in sheep and the veterinary surgeon has the 
important role of improving sheep welfare in the experimental and clinical 
setting. 
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ANNEX A: On line questionnaire sent to Italian 
practitioners regarding analgesia in breeding sheep 
 
QUESTIONARIO SULL' ANALGESIA NELLA SPECIE 
OVINA 
*Campo obbligatorio 
 
PARTE I 
Per favore, rispondi alle seguenti domande. E' possibile indicare più di una 
risposta. 
 
In che anno ti sei laureato/a? *   
 
Hai effettuato studi post-lauream? * 
o  Master  
o  Dottorato di ricerca  
o  Scuola di specializzazione  
o  Diploma Europeo  
o  Non ho effettuato studi post-lauream  
o  Altro: 
 
Sesso: * 
o  Maschio  
o  Femmina  
In che regione lavori? *  
 
Di quali specie animali ti occupi? * 
o  Specie ovina  
o  Specie caprina  
o  Specie bovina  
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o  Specie equina  
o  Altro:  
 
Che percentuale del tuo tempo dedichi alla cura della specie ovina? * 
o  0-30%  
o  30-50%  
o  50-70%  
o  100%  
 
Quale è la grandezza media del gregge con cui hai a che fare? * 
o  1-10 capi  
o  10-50 capi  
o  50-100 capi  
o  più di 100 capi  
 
 
Qual è l'attitudine degli ovini a cui dedichi le tue cure? * 
o  Carne  
o  Latte  
o  Lana  
o  Mista  
o  Sperimentazione  
o  Compagnia  
o  Altro:  
 
PARTE II 
Le seguenti domande riguardano l'uso di analgesici/tecniche analgesiche 
nel periodo peri-operatorio nella specie ovina. Per periodo peri-operatorio 
si intende il periodo che intercorre tra l'inizio dell'anestesia fino a 24 ore 
dopo la procedura. Per favore, indica quali farmaci/tecniche utilizzi per 
fornire analgesia nella specie ovina, anche in deroga secondo normativa 
vigente. E' possibile indicare più di una risposta. 
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Oppioidi. Quale dei seguenti farmaci utilizzi? * 
o  Butorfanolo  
o  Buprenorfina  
o  Metadone  
o  Morfina  
o  Petidina  
o  Nessuno  
o  Altro:  
 
Somministri abitualmente oppioidi nel periodo perioperatorio in 
pecore sottoposte a chirurgie (es. castrazione, decornuazione, cesareo, 
laparotomia, etc)? Se si, quando somministri gli oppioidi? * 
o  Non utilizzo oppioidi abitualmente  
o  Prima dell'anestesia  
o  All' inizio dell'anestesia o durante la chirurgia  
o  Dopo la chirurgia  
 
Se non somministri abitualmente gli oppioidi nella specie ovina, li 
somministri in qualche circostanza particolare? * 
o  Si  
o  No  
 
Se si, in che particolare circostanza somministri gli oppioidi?  
        
 
In base a quale criterio scegli l'oppioide da somministrare? * 
o  Non somministro oppioidi  
o  Efficacia analgesica  
o  Sicurezza riportata  
o  Costi  
o  Reperibilità  
o  Altro:  
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Farmaci anti-infiammatori non steroidei. Quale dei seguenti farmaci 
utilizzi? * 
o  Acido tolfenamico  
o  Carprofen  
o  Fenilbutazone  
o  Flunixin meglumine  
o  Ketoprofene  
o  Meloxicam  
o  Non dispongo di farmaci anti-infiammatori non steroidei  
o  Altro:  
 
Somministri abitualmente farmaci anti-infiammatori non steroidei 
(FANS) nel periodo perioperatorio in pecore sottoposte a chirurgie 
(es. castrazione, decornuazione, cesareo, laparotomia, etc)? Se si, 
quando somministri i FANS? * 
o  Prima dell'anestesia  
o  All'inizio dell'anestesia o durante la chirurgia  
o  Dopo la chirurgia  
o  Non utilizzo abitualmente FANS  
 
Per il trattamento di quali patologie somministri i FANS? * 
o  Zoppie  
o  Mastiti  
o  Ascessi  
o  Altro:  
 
In base a quale criterio scegli i FANS da somministrare? * 
o  Registrazione per la specie ovina  
o  Efficacia analgesica  
o  Tempi di sospensione  
o  Sicurezza riportata  
o  Costi  
o  Reperibilità  
o  Altro:  
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Anestetici locali. Quale dei seguenti farmaci utilizzi?  
o  Procaina  
o  Bupivacaina  
o  Lidocaina  
o  Non dispongo di anestetici locali  
o  Altro:  
 
Somministri abitualmente anestetici locali nel periodo perioperatorio 
in pecore sottoposte a chirurgie (es. castrazione, decorazione, cesareo, 
laparotomia, etc)? * 
o  Si  
o  No  
 
Quale delle seguenti tecniche loco-regionali utilizzi? * 
o  Infiltrazione di anestetico locale attorno al punto di incisione 
della cute  
o  Blocco intratesticolare per castrazione  
o  Anestesia epidurale per procedure su addome e perineo  
o  Anestesia epidurale per procedure sugli arti posteriori  
o  Infiltrazione di anestetico locale attorno al dente per procedure 
dentali  
o  Blocco del nervo mandibolare/mascellare per procedure dentali  
o  Blocco del plesso brachiale  
o  Non utilizzo tecniche loco regionali  
o  Altro:  
 
Che farmaci utilizzi quanto effettui un'epidurale? * 
o  Anestetico locale  
o  Anestetico locale e oppioide  
o  Non effettuo epidurali  
o  Altro:  
 
Altri farmaci. Quale dei seguenti farmaci utilizzi? * 
o  Detomidina  
o  Dexmedetomidina  
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o  Medetomidina  
o  Romifidina  
o  Xylazina  
o  Ketamina  
o  Farmaci anti-infiammatori steroidei  
o  Farmaci omeopatici  
o  Nessuno di questi  
o  Altro:  
 
Hai mai somministrato tramadolo nella specie ovina? * 
o  Si  
o  No  
 
Se si, in che circostanza/patologia hai utilizzato il tramadolo?  
        
 
A che dose e per quanto tempo hai somministrato il tramadolo?  
        
 
Hai notato effetti collaterali dopo la somministrazione di tramadolo?  
o  Si  
o  No  
 
Se hai notato effetti collaterali, quale dei seguenti hai notato dopo la 
somministrazione di tramadolo?  
o  Agitazione  
o  Atassia  
o  Tremore  
o  Tachipnea  
o  Tachicardia  
o  Altro:  
 
Per apportare analgesia, quali altre tecniche utilizzi? * 
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o  Agopuntura  
o  Chiropratica  
o  Nessuna di queste  
o  Altro:  
 
PARTE IV 
Le seguenti domande riguardano l'uso di analgesici nel periodo peri-operatorio 
nella specie ovina. Per periodo peri-operatorio si intende il periodo che intercorre 
tra l'inizio dell'anestesia fino a 24 ore dopo la procedura. E' possibile indicare più 
di una risposta. 
 
Che farmaci utilizzi per le castrazioni? * 
o  Alpha 2 agonista  
o  FANS  
o  Ketamina  
o  Anestetico locale  
o  Nessuno  
o  Altro:  
Che farmaci utilizzi per le decornuazioni? * 
o  Alpha 2 agonista  
o  FANS  
o  Ketamina  
o  Anestetico locale  
o  Nessuno  
o  Altro:  
 
Che farmaci/tecniche usi per un cesareo? * 
o  Alpha 2 agonista  
o  FANS  
o  Ketamina  
o  Epidurale  
o  Infiltrazione di anestetico locale sul fianco  
o  Oppioidi per via sistemica  
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o  Nessuno  
o  Altro:  
 
PARTE V 
Per favore, rispondi alle seguenti domande. E' possibile indicare più di una 
risposta. 
 
Indica in una scala da 1 a 10, dove 1 indica assenza di dolore e 10 il 
peggior dolore possibile, quale intensità di dolore prova una pecora 
durante/dopo la castrazione? * 
 1 2 3 4 5 6 7 8 9 10  
                      
 
Indica in una scala da 1 a 10, dove 1 indica assenza di dolore e 10 il 
peggior dolore possibile, quale intensità di dolore prova una pecora 
durante/dopo la decornuazione? * 
 1 2 3 4 5 6 7 8 9 10  
                      
 
Indica in una scala da 1 a 10, dove 1 indica assenza di dolore e 10 il 
peggior dolore possibile, quale intensità di dolore prova una pecora 
durante/dopo un cesareo? * 
 1 2 3 4 5 6 7 8 9 10  
                      
 
Indica in una scala da 1 a 10, dove 1 indica assenza di dolore e 10 il 
peggior dolore possibile, quale intensità di dolore prova una pecora 
affetta da frattura ossea? * 
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 1 2 3 4 5 6 7 8 9 10  
                      
 
Indica in una scala da 1 a 10, dove 1 indica assenza di dolore e 10 il 
peggior dolore possibile, quale intensità di dolore prova una pecora 
affetta da mastite? * 
 1 2 3 4 5 6 7 8 9 10  
                      
 
Indica in una scala da 1 a 10, dove 1 indica assenza di dolore e 10 il 
peggior dolore possibile, quale intensità di dolore prova una pecora 
affetta da zoppia? * 
 1 2 3 4 5 6 7 8 9 10  
                      
 
Indica in una scala da 1 a 10, dove 1 indica assenza di dolore e 10 il 
peggior dolore possibile, quale intensità di dolore prova una pecora 
con un ascesso? * 
 1 2 3 4 5 6 7 8 9 10  
                      
 
Quali atteggiamenti riconosci in una pecora che prova dolore? * 
o  Diminuzione della locomozione  
o  Immobilità  
o  Diminuzione dell'interazione con  le altre pecore  
o  Diminuzione dell'alimentazione e abbeveraggio  
o  Diminuzione dell'attività reticolo-ruminale  
o  Calci / leccamento / sfregamento della zona dolorante  
o  Digrignamento dei denti  
 
 
 
 
148 
 
o  Tachicardia  
o  Iperventilazione  
o  Nessuna di queste  
o  Altro:  
 
Secondo il tuo parere, per quali motivi l'utilizzo dell'analgesia nella 
specie ovina è limitato? * 
o  Mancanza di farmaci registrati per l'uso negli ovini  
o  Motivi economici  
o  Tempi di attesa dopo la somministrazione del farmaco  
o  Incombenze burocratiche  
o  Nessuno di questi  
o  Altro:  
PARTE VI 
Per favore, rispondi alle seguenti domande. E' possibile indicare più di una 
risposta. 
 
Consideri adeguata la tua conoscenza nell'ambito della terapia del 
dolore nella specie ovina? * 
o  Si  
o  No  
 
Come preferiresti aggiornare le tue conoscenze riguardo la terapia del 
dolore nella specie ovina? * 
o  Riviste specialistiche  
o  Congressi / Seminari  
o  Aggiornamento a distanza  
o  Non mi interessa l'argomento  
o  Altro:  
GRAZIE MILLE PER AVER COMPILATO QUESTO 
QUESTIONARIO! 
 
 
 
